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Preface
Dopamine is a multifunctional molecule known to be involved in many neural
processes including reward, executive functions, and sensorimotor processing (Schultz,
2010). Dopamine operates at the synapse on the order of milliseconds, and the magnitude
and timing of phasic release is critical for understanding how variation in release can
relate to behavioral functions or pathology (Tsai et al., 2009; Venton et al., 2003). Fixedpotential amperometry (FPA) combined with carbon fiber microelectrodes has proven to
be effective at probing dopaminergic microsystems and precisely describing the kinetic
mechanisms that regulate the phasic response (Fathali & Cans, 2018; Lester, Rogers, &
Blaha, 2010; Mosharov & Sulzer, 2005). Chapter 1 includes applications of in vivo fixed
potential amperometry (FPA) in exploring normal and pathological function of
dopaminergic circuitry and is followed by two separate manuscripts. The first study
(Chapter 2) has been formatted for submission to the journal Synapse and provides a
systematic examination of phasic transmission in the four predominant output regions of
the nigrostriatal and mesocorticolimbic pathways using FPA in anesthetized mice.
Chapter 3 is formatted according to APA guidelines and presents data on the use of
amperometry for investigating dopamine dysfunction in a mouse model of autism as well
as assessing the cerebellar role in modulating the nigrostriatal dopamine system. Chapter
4 focuses on cerebellar-mediated asymmetry in the mesolimbic dopamine system through
examining projections from the cerebellar dentate (DN) to the nucleus accumbens and
has been formatted according to APA guidelines. The final chapter (Chapter 5) provides
an overall summary of the amperometric experiments and discusses the implications of
the results.
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Abstract
Holloway, Z. R., Ph. D. The University of Memphis. December, 2018. Examining
Cerebellar Modulation of Mesolimbic Dopamine Transmission Using Fixed Potential
Amperometry. Major Professors: Deranda B. Lester, Ph.D. and Helen J. Sable, Ph. D.

Elucidating how dopamine neurons operate regularly in aspects of neurochemical release
and in pathological systems is essential for understanding their role in behavior, drug
treatment, and disease. Fixed-potential amperometry (FPA) combined with carbon fiber
microelectrodes has proven to be effective at probing these dynamic microsystems and
precisely describing the regulatory mechanisms that govern dopamine neurotransmission.
To date, we have utilized FPA to: a) observe and quantify differences in the
neurochemical profile of phasic dopamine release in major dopaminergic afferents
including the striatum, nucleus accumbens (NAc), amygdala, and prefrontal cortex
through stimulation of the medial forebrain bundle (MFB), b) provide evidence that
differing behavioral processes in the brain emerge from spatial and temporal variations in
the phasic response, and c) identify a pathway originating in the cerebellar dentate that
projects to nigrostriatal and mesolimbic systems, solidifying the role of the cerebellum in
higher cognitive functions and neuropathology related to dopamine dysfunction. These
findings provide evidence that the cerebellum regulates dopamine release in the
cerebrum, and previous literature has shown that dopaminergic systems in the bilateral
cerebral hemispheres contribute asymmetrically to behavior, structure, and function. To
determine whether asymmetrical lateralization in the dopaminergic system occurs at the
level of the cerebellum, cerebrum, or both, FPA was used to examine asymmetry of
dopamine release in the dentate nucleus (DN)-NAc and MFB-NAc pathways. We found
significant differences in the amplitude of phasic dopamine release in the DN-NAc
systems, but not the MFB-NAc pathways. Results from this study support the notion that
reward processes in the brain may be lateralized between cerebrocerebellar networks,
with greater phasic release occurring in projections from the left cerebellar DN to the
right NAc. These studies may provide more detailed information about the relationship
between the cerebrocerebellar networks and lateralization of the dopaminergic system as
well as potentially reveal novel targets for pharmacological interventions in
neuropathology of the cerebellum.
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CHAPTER 1: ELECTROCHEMICAL DETECTION OF DOPAMINE
DYNAMICS
Introduction
Basal Versus Phasic Dopamine Release
The nigrostriatal dopamine system consists of dopamine cell bodies in the
substantia nigra pars compacta (SNc) that project to the dorsal striatum and play a role in
the expression of motor processes (Horvitz, 2000; Parent & Hazrati, 1995). The other
major dopaminergic circuit, the mesocorticolimbic dopamine system, consists of cell
bodies in the ventral tegmental area (VTA) that project to the amygdala, nucleus
accumbens (NAc), and medial prefrontal cortex (mPFC) (Fibiger & Phillips, 1988; Koob
& Swerdlow, 1988). Rather than motor acts, the purpose of these structures is to finetune aversive, reward, and cognitive processes, respectively (Davis, 1992; Lee, Lee, &
Kim, 2017; Matsumoto & Hikosaka, 2009; Seamans & Yang, 2004). Dopamine neurons
mediate behavior by using two bursting modes. Basal dopamine is generated when
neurons are tonically active at slow rates (~4 Hz), producing low concentrations of
extracellular dopamine; this occurs when no behaviorally relevant stimuli are present
(Goto, Otani, & Grace, 2007). Conversely, when presented with sensory signals
predicting rewards or aversive events, these cell bodies fire phasically at high frequencies
and serve as a learning signal (Schultz, Apicella, & Ljungberg, 1993; Venton et al.,
2005). Phasic release occurs in response to salient information and leads to elevated
levels of extracellular dopamine, and this transient rise can influence motor output in
behavioral situations (Phillips et al. 2003; Robinson et al. 2002). Dopamine operates at
the synapse on the order of milliseconds, and the magnitude and timing of phasic release
is critical for many diverse functions including reward, attention, anxiety, and decision1

making (Tsai et al., 2009.) These differing behavioral processes emerge from variations
in autoreceptor, uptake, and release sites, which lead to site-specific differences in
dopamine concentrations during synchronous phasic firing (Venton et al., 2003).
Quantitative predictions of how the phasic dopamine response operates in major midbrain
afferents of the mesocorticolimbic and nigrostriatal systems are crucial for understanding
the influence of dopamine on behavior and for the development efficient treatments for
disorders related to dopamine dysfunction.
Electrochemical Measures of Dopamine
The ability to electrochemically measure dopamine release and properties related
to dopamine kinetics during pharmacological treatments and behavioral tests has greatly
advanced the study of dopaminergic neurotransmission. Analysis of many vital
dopaminergic events in the brain requires an electrochemical technique with superb
filtering, signal-to-noise ratio, sampling rate, and chemical selectivity (Michael &
Wightman, 1999). Although techniques like microdialysis have been used to monitor
slow or tonic alterations in neurotransmitter levels spanning minutes (Borland et al.
2005), the rapid chemical changes that occur during phasic release require a more
suitable approach. Fast-scan cyclic voltammetry (FSCV) is a popular method used to
measure subsecond dopamine efflux and has excellent chemical selectivity with a high
sampling rate (10 times per second) (Garris & Wightman, 1994). However, analysis of
the phasic response in the synaptic space requires a technique with an instantaneous
response to DA release.
In vivo fixed-potential amperometry (FPA) offers the best temporal resolution
available (10,000 samples per second) and previous studies have shown FPA coupled
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with carbon-fiber DA recording microelectrodes to be a valid technique for real-time
monitoring of stimulation-evoked DA release (Agnesi, Blaha, Lin & Lee, 2010; Agnesi et
al., 2009; Forster & Blaha, 2003).
The high sampling rate of FPA permits the quantification of the transmitter
molecules released from individual vesicles, which provides valuable information about
the real-time kinetics and homeostatic mechanisms involved in dopamine release during
exocytosis (Mosharov & Sulzer, 2005). However, amperometry has poor chemical
selectivity because other monoamines such as serotonin and norepinephrine are also
oxidized at +0.8 V. Therefore, after baseline dopamine release has been established,
animals can be injected systemically with either saline as a control, a dopamine uptake
blocker, a serotonin uptake blocker, or a norepinephrine uptake blocker to validate that
dopamine was the oxidized molecule being monitored in the experiments. Thirty minutes
after injection is considered to be efficient time for the drug to be absorbed and if
dopamine is the molecule being recorded, only the dopamine uptake blocker will elevate
extracellular levels (Mittleman et al., 2011; Tye, Miller, & Blaha, 2013). Saline along
with the other uptake blockers cause no significant changes in dopamine oxidation
current due to their molecular properties and binding sites. The flexibility of this
electrochemical approach not only allows for quantification of DA release with excellent
signal-to-noise ratio, but also for additional aspects of phasic transmission such as uptake,
autoreceptor sensitivity, overall dopamine supply, and changes in dopamine half-life
following various uptake blockers (Fielding et al., 2013; Lester, Rogers, & Blaha, 2010;
Mittleman et al., 2011).
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Electrochemistry of Fixed Potential Amperometry
Electrochemical detection of release of oxidizable neurotransmitters in FPA
requires a three-electrode configuration that incorporates an auxiliary electrode, reference
electrode, and a recording electrode, and recordings are performed within a Faraday cage
to increase the signal to noise ratio and eliminate static interference (Blaha & Phillips,
1996; Forester & Blaha, 2003). An electrometer and analog to digital chart recorder form
a circuit between the three electrodes, and a fixed continuous potential (+0.8 V) is applied
to the recording electrode via the auxiliary electrode, while maintaining a potential
difference between the recording and reference electrode (Blaha and Phillips, 1992). By
applying a positive potential to the carbon fiber recording electrode, exocytotic activity
from dopamine neurons is observed as amperometric spikes, referred to as oxidation
current, which is caused by the transfer of electrons after monamine oxidation (Mosharov
& Sulzer, 2005). The positive potential of the electrode is constant, so dopamine
oxidation current is always directly proportional to the concentration of dopamine
(Michael & Wightman, 1999). Responses become smaller and wider as diffusional
distance of the neurotransmitter concentration from the recording electrode increases
(Chow & von Ruden, 1995; Evanko, 2005). The amplitude and duration of spikes give
notion to the quantal size of the release event (Bruns, 2004). Dopamine can act locally at
receptors adjacent to release sites or diffuse further to remote receptors, and the
characteristics of individual spikes provide information about how dopamine signaling
varies in distinct neural systems with assorted behavioral functions (Mosharov & Sulzer,
2005).
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Measuring Stimulated Dopamine Release
Modeling a particular neural region in mice requires stereotaxic coordinates for
the system and can be found in relation to bregma, midline, and dura in the mouse atlas
of Paxinos and Franklin (2001). In each mouse, a concentric bipolar stimulating electrode
is typically implanted at the origin of the nigrostriatal and mesocorticolimbic
dopaminergic circuitry in midbrain, or the bundle of axons known as the medial forebrain
bundle (MFB) extending from these cell bodies. Stimulation of the MFB has been shown
to evoke dopamine release in all four major terminal regions (Garris & Wightman, 1994;
Jones, Harris, Kilts, & Wightman 1995).
The FPA set-up also requires a stainless-steel auxiliary and Ag/AgCl reference
electrode combination is placed on the surface of contralateral cortical tissue, and a
carbon fiber recording electrode is positioned in the synaptic space near a secretory cell
of interest. Stimulation protocols vary between experiments, but often consist of short
monophasic pulses (400-800 µAmps) at 20-50 Hz to establish a baseline dopamine
response. The amplitude and duration of the of the response observed immediately after
stimulation is representative of the dopamine oxidation current in the synaptic space of
the observed area and is typically converted into dopamine concentration. This
conversion typically requires a flow injection system and in vitro calibration of the
recording electrodes in dopamine solutions (0.2-1.2 µM) after recording electrodes have
been removed from the brain (Michael & Wightman, 1999). Change in dopamine
oxidation current (nAmp) can then be converted to dopamine concentration (µM). FPA
allows for a systematic quantification of DA release, and can also be used to examine
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mechanisms that regulate the dopaminergic profile, such as autoreceptor functioning,
dopamine supply levels, and the dopamine transporter.
Dopamine Autoreceptor Functioning
Presynaptic inhibition allows for neurons to modulate their own neurotransmitter
release through the function of neurotransmitter-specific autoreceptors (Stark et al.,
1989). In vivo, the onset of D2 inhibition is maximal between 150 and 300 ms after the
end of the initial conditioning stimulation (Benoit-Marnand et al., 2001). The sensitivity
autoreceptors can be assessed with amperometry by using five sets of conditioning pulses
or pre-pulses (1, 5, 10, 20, and 40 pp), delivered 300ms prior to the second test
stimulation (T2), in which T2 has a stimulation protocol similar to that of recording
stimulation-evoked baseline release. T2 can then be compared to an identical prior
stimulation (T1) which does not follow pre-pulses. Pre-pulses before test stimulations
evoke enough dopamine to bind to D2 receptors and activate the autoreceptor function.
By increasing the amount of pre-pulses prior to stimulation it is possible to observe
various levels of autoreceptor activation and efficacy. Low-to-high autoreceptor
sensitivity is indicated by low-to-high percent inhibition of evoked dopamine efflux, such
that high sensitivity would result in a lower amplitude of the stimulation-event with prepulses (T2) compared to the event with no pre-pulses (T1).
Presynaptic Dopamine Depletion
Each dopamine terminal has a reserve of neurotransmitters available for release
when challenged environmentally or experimentally, via pharmaceuticals or electrical
stimulation (Pothos, Davila, & Sulzer, 1998; Willuhn, Burgeno, Groblewski, & Phillips,
2014). Assessment of the overall dopamine supply level can be experimentally tested
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with amperometry in output modules of the nigrostriatal and mesocorticolimbic system
using a continuous 3 min stimulation (20-50hz) to completely deplete neuronal reserves
(Fielding et al., 2013). Functional differences in reserves of these modules may provide
useful insight to the application of medications which rapidly elevate the extracellular
concentration of dopamine in the brain, such as amphetamine formulations in treatments
for ADHD (James et al., 2001; Kahlig & Galli 2003).
Presynaptic Dopamine Transporters
After obtaining baseline recordings of dopamine efflux with amperometry,
dopamine uptake can be quantified by measuring dopamine half-life decay, which is the
time for 50% decrease from the maximum evoked amplitude to the pre-stimulation
baseline level. Amperometric measurements of half-life decay are an indicator of DAT
functioning and allow for pharmaceutical challenges including reuptake blockade
(Benoit-Marand, Jaber, & Gonon, 2000; Mittleman et al., 2011). Analysis of various
reuptake blockers within a dopaminergic system can also be used to validate that
dopamine was the oxidized molecule being monitored in the experiments.
Summary and Conclusions
Amperometry is a powerful analytical tool and is one of the few methods
providing quantitative information about single-vesicle neurotransmitter release
(Mosharov & Sulzer, 2005; Wightman et al., 1991). The relative simplicity of its design
and experimental set-up equip the researcher with the capability to examine any neural
system or model of neuropathological illness, and the temporal resolution of this
technique (10,000 sample/sec) is higher than any current electrochemical method.
Amperometric techniques combined with carbon fiber microelectrodes have confirmed
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their effectiveness at probing these ultra-small systems and precisely describing the
regulatory mechanisms that govern dopamine neurotransmission. Elucidating how
dopamine neurons operate regularly in aspects of neurochemical release and in
pathological systems is essential for interpreting their respective roles in behavior, drug
treatment, and disease, and amperometry provides a especially useful tool to explore
uncharted dopaminergic territory.
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CHAPTER 2: COMPARING PHASIC DOPAMINE DYNAMICS IN THE
STRIATUM, NUCLEUS ACCUMBENS, AMYGDALA, AND MEDIAL
PREFRONTAL CORTEX
Introduction
Neural modules involved in emotion, reward, executive functions, and actionselection are all regulated by the same chemical signal, bursts of dopamine (DA), which
originate from neuronal firing deep within the midbrain (Schultz, 2010). Dopaminergic
axons from the midbrain are distributed to multiple brain regions in two independent,
parallel circuits—the nigrostriatal and mesocorticolimbic dopamine pathways—each
projecting to many highly interconnected modules of the basal ganglia, limbic system,
and frontal cortex. The modules and their interconnecting feedback networks make up
larger systems termed the motor, motivational, and associative corticostriatal loops,
which are independent neural networks reciprocally connecting the basal ganglia and
other subcortical nuclei with the cerebral cortex (McHaffie, Stanford, Stein, Coizet, &
Redgrave, 2005; Seger, 2009). Dopamine has a major role in regulating the activity of
these loops (Voorn, Vanderschuren, Groenewegen, Robbins, & Pennartz, 2004; Haber,
2014; Haber, Kim, Mailly, & Calzavara, 2006).
The nigrostriatal dopamine system consists of dopamine cell bodies in the
substantia nigra pars compacta (SNc) that project to the dorsal striatum, a prominent part
of the motor loop (Parent & Hazrati, 1995). Dopamine in the striatum is necessary for the
initiation of voluntary movement, and dysregulation of the nigrostriatal dopamine system
can result in severe deficits in movement initiation and execution, such as the cardinal
motor symptoms of Parkinson’s disease (Lewis, Slabosz, Robbins, Barker, & Owen,
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2005; Schultz et al.,1989). Dopamine receiving nuclei in the mesocorticolimbic and
nigrostriatal pathways are distinguished by their unique roles in behavior, but it remains
unclear how underlying dopamine transmission varies in these different regions.
The mesocorticolimbic dopamine system consists of cell bodies in the ventral tegmental
area (VTA) that project to the amygdala, nucleus accumbens (NAc), and medial
prefrontal cortex (mPFC) (Fibiger & Phillips, 1988; Koob & Swerdlow, 1988). These
systems are an integral part of the motivational loop, in which the medial network of the
frontal cortex projects not only to the nucleus accumbens, but also the striatum which
receives inputs from the amygdala (Ikemoto, Yang, & Tan, 2015). Dopamine in the
amygdala is important for recognition and regulation of fear memories (Lee, Lee, & Kim,
2017), and pathology within this system is associated with anxiety disorders (Davis,
1992). Dopamine release in the NAc codes for reinforcement of internal and external
rewards, and electrophysiological recordings of dopamine cell bodies in the VTA have
shown these cells increase their firing rates in response to the presentation of salient,
rewarding stimuli and decrease firing in response to negative stimuli (Cohen, Haesler,
Vong, Lowell, & Uchida, 2012; Matsumoto & Hikosaka, 2009; Mirenowicz & Schultz,
1996; Robinson, Howard, McConnell, Gonzales, & Wightman, 2009). Most drugs of
abuse increase extracellular NAc dopamine levels, which can lead to addiction (Di
Chiara, 2002; Russo et al., 2010). Addiction has been described as the pathology of
motivation, in which the entire pathway of goal-directed behavior undergoes pathological
modification (Kalivas & Volkow, 2005). Electrophysiological recordings indicate that
dopamine neurons innervating the mPFC are functionally distinct from those projecting
to the NAc, therefore differing behavioral functions are to be expected as well (Bannon &
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Roth, 1983). Dopamine in the mPFC is thought to influence many cognitive functions
that support associative learning, such as working memory, planning, and attention;
furthermore, dysfunctions in mPFC dopamine may underlie both positive and negative
symptoms and cognitive deficits associated with schizophrenia (Popescu, Zhou, & Poo,
2016; Seamans & Yang, 2004).
In freely moving rats, dopamine neurons fire tonically at ~4hz and burst fire
phasically at ~20hz (Hyland et al., 2002). Tonic firing is suggested to occur when no
behaviorally relevant stimuli are present and produces low concentrations of extracellular
dopamine (Goto, Otani, & Grace, 2007). Conversely, it has been suggested that phasic
firing occurs in relation to behaviorally significant external stimuli whose detection is
crucial for learning (Schultz, Apicella, & Ljungberg, 1993). This mode of firing is
thought to evoke a large enough extracellular concentration for the highlighting of salient
stimuli in the environment (Middleton and Strick, 2000). In an experimental setting, the
frequency with which these neurons are electrically stimulated determines their effects on
release; 25 pulses at 50hz elevates the extracellular concentration sufficient for reward,
but 25 pulses at 1hz does not due to the fast action of the uptake system (Bass et al.,
2010; Ikemoto, Yang, & Tan, 2015; Tsai et al., 2009). The multifunctionality of
dopamine, juggling aspects of behavior such as action-selection, emotion, and motivation
likely lie at the individual synapses, with varied amount of phasic dopamine release
acting on different receptor populations.
Previous studies have shown regional differences in phasic dopamine
transmission. Although release concentrations were found to be similar across regions,
the rate of dopamine uptake was slower in the amygdala and mPFC compared to the NAc
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and striatum (Garris & Wightman, 1994). Furthermore, these areas have previously been
found to respond differently to dopamine agonists. Dopamine uptake blockers, such as
cocaine and nomifensine, had no effect in the amygdala but greatly increased
extracellular dopamine concentrations in the NAc and striatum (Jones, Garris, Kilts, &
Wightman, 1995). It should be noted that these studies were conducted using fast-scan
cyclic voltammetry (FSCV) in brain slices. FSCV has excellent chemical selectivity and
can accurately quantify sub-second dopamine efflux, sampling every 100ms (10 times per
second) (Garris & Wightman, 1994). However, in vivo FPA has the best temporal
resolution available (10,000 samples per second) and is more suitable for documenting
rapid dopaminergic events at the synapse. Thus, we employed this technique in the
current study.
Given that chemical selectivity is lacking with fixed potential amperometry, we
pharmaceutically confirmed that our recordings are dopamine-dependent using uptake
blockers targeting various neurotransmitters. With this electrochemical technique, it is
possible not only to quantify dopamine release and uptake (an indication of dopamine
transporter [DAT] functioning) with excellent signal to noise ratio, but also examine
additional aspects of phasic dopamine transmission, such as dopamine autoreceptor
sensitivity, overall dopamine supply, and changes in dopamine half-life following the
uptake blockers (Fielding et al., 2013; Lester, Rogers, & Blaha, 2010; Mittleman et al.,
2011). This study provides a comprehensive, systematic examination of phasic dopamine
transmission in the 4 predominant neural output regions of the nigrostriatal and
mesocorticolimbic pathways using fixed potential amperometry in anesthetized mice.
Many drugs, both therapeutic and recreational, alter dopamine levels; thus, an
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understanding of regional differences in dopamine transmission can lead to increased
knowledge about the influence of dopamine on behavior and more efficient treatments for
disorders related to dopamine dysfunction.
Materials and Methods
Animals
Fifty-six male C57BL/6J mice (Jackson Laboratories, ME) were housed 3-5 per
cage in a temperature-controlled environment (21±1 °C) on a 12 hr light/dark cycle with
(lights on at 0600) and given food and water available ad libitum. All experiments were
approved by the Institutional Animal Care and Use Committee at the University of
Memphis and conducted in accordance with the National Institutes of Health Guidelines
for the Care and Use of Laboratory Animals. Efforts were made to reduce the number of
animals used and to minimize pain and discomfort.
Surgery
Mice were anesthetized with urethane (1.5 g/kg, i.p.) and placed in a stereotaxic
frame (David Kopf Instruments, Tujundga, CA) ensuring flat skull. Body temperature
was maintained at 36 ± 0.5 °C with a temperature-regulated heating pad (TC-1000; CWE,
NY). All stereotaxic coordinates are in mm from bregma, midline, and dura according to
the mouse atlas of Paxinos and Franklin (2001). In each mouse, a concentric bipolar
stimulating electrode (SNE-100, Rhodes Medical, CA) was implanted into the left medial
forebrain bundle (MFB) (AP -2.0, ML +1.1, and DV -4.0), which consists of
dopaminergic axons from the SNc and VTA that project to subcortical and cortical sites.
A stainless-steel auxiliary and Ag/AgCl reference electrode combination was placed on
the surface of contralateral cortical tissue -2.0 mm from bregma, and a carbon fiber
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recording electrode was positioned in either the left striatum (AP +1.5, ML +0.8, and DV
-2.8), NAc (AP +1.5, ML +0.8, and DV -3.8), amygdala (AP +2.4, ML +0.35, and DV 1.2), or mPFC (AP +2.35, ML +1.0, and DV -2.0) (n = 14 mice per recording site).
Given our success recording stimulation-evoked dopamine in the striatal regions (Lester,
Miller, Pate, & Blaha, 2008; Lester, Rogers, & Blaha, 2010), prior to recording in the
amygdala or mPFC, an optimal stimulation-evoked response was found in the NAc to
ensure proper placement of the stimulating electrode in the MFB. Recording electrodes
were then moved to either the amygdala or mPFC. Fixed potential amperometry, also
known as continuous amperometry, coupled with carbon fiber recording microelectrodes
has previously been confirmed as a valid technique for real-time monitoring of
stimulation-evoked dopamine release in the nucleus accumbens, striatum and other brain
systems (Dugast, Suaud-Chagney, & Gonan, 1994; Forster & Blaha, 2003; Lester,
Rogers, & Blaha, 2010; Suaud‐Chagny et al., 1995). All amperometric recordings were
made within a Faraday cage to increase signal to noise ratio. A fixed potential (+0.8 V)
was applied to the recording electrode, and oxidation current was monitored continuously
(10K samples/sec) with an electrometer (ED401 e-corder 401 and EA162 Picostat, eDAQ
Inc., Colorado Springs, CO) filtered at 50 Hz.
Electrical stimulation and drug administration
Following surgical set-up, a series of cathodal current pulses was delivered to the
stimulating electrode via an optical isolator and programmable pulse generator (IsoFlex/Master-8; AMPI, Jerusalem, Israel). Stimulation parameters varied depending on
the aspect of dopamine transmission being measured. Initially, the stimulation protocol
consisted of 20 monophasic 0.5 ms duration pulses (800 µAmps) at 50 Hz every 30

20

seconds to establish a baseline dopamine response. To account for transient electrical
stimulation artifacts, the fixed-potential of the recording electrode was also set to 0V in
each brain area and the response was subtracted from recordings at +0.8 V to ensure an
absolute dopaminergic baseline response is being monitored (Dugast, Suaud-Chagney, &
Gonan, 1994; Benoit-Marand, Borrelli, & Gonan, 2001).
Dopamine autoreceptor sensitivity was assessed by adapting previous in vivo
methods used in examination of dopaminergic neurons (Benoit-Marand, Borrelli, &
Gonan, 2001). The current study applied a pair of test stimuli (T1 and T2, each 10 pulses
at 50 Hz with 10 sec between T1 and T2) to the MFB every 30 sec (Fielding et al., 2013;
Mittleman et al., 2011). Five sets of conditioning pulses (1, 5, 10, 20, and 40; 0.5 ms
pulse duration at 15 Hz) were delivered prior to T2 such that there was 0.3 s between the
end of the conditioning pulse train and initiation of T2. Autoreceptor-mediated inhibition
of evoked dopamine efflux was expressed in terms of the change in the amplitude of T2
with respect to T1 for each set of conditioning pulses; low-to-high dopamine autoreceptor
sensitivity was represented as low-to-high percent inhibition of evoked dopamine efflux
(i.e. high sensitivity results in a lower amplitude of T2 relative to T1).
Upon completion of the autoreceptor sensitivity test, stimulation parameters were
reset to 20 pulses at 50 Hz every 30 sec. Baseline levels of MFB stimulation-evoked
dopamine were monitored for 10 min in each mouse prior to drug administration. From
these baseline recordings, we quantified dopamine release (the magnitude of the
response) and dopamine uptake, an indication of DAT functioning (measured by
dopamine half-life decay, i.e. the time for 50% decrease from the maximum evoked
increase to the prestimulus baseline level) (Benoit-Marand, Jaber, & Gonon, 2000;
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Mittleman et al., 2011). Following this baseline recording, animals were injected
systemically (i.p.) with uptake blockers. In order to validate that dopamine was the
oxidized molecule being monitored in these experiments, separate groups of mice
received i.p. injections of either saline (control, 0.9%), the dopamine uptake blocker
nomifensine (10 mg/kg), or the selective-serotonin uptake blocker fluoxetine (10 mg/kg)
and the norepinephrine uptake blocker desipramine (10 mg/kg) with a 30 min recording
period following each injection (Mittleman et al., 2011; Tye, Miller, & Blaha, 2013). To
reduce the number of mice used, the latter group of mice received a fluoxetine injection,
followed by 30 min of amperometric recordings, then a desipramine injection, following
by another 30 min recording period. Next, a 3 min continuous stimulation was applied to
assess overall dopamine supply levels (Fielding et al., 2013). At conclusion of the
amperometric recordings, recording electrodes were removed from the brain for in vitro
calibration using dopamine solutions (0.2-1.2 µM) administered with a flow injection
system (Michael & Wightman, 1999; Prater, Swamy, Beane, & Lester, 2018). Thus,
change in dopamine oxidation current (µAmp) was converted to dopamine concentration
(µM).
Data analysis
To quantify MFB stimulation-evoked dopamine efflux, pre-stimulation current
values were normalized to zero current values and data points occurring within a range of
0.25 sec pre- and 5 sec post-onset of the stimulation were extracted from the continuous
record at the desired time points. Changes in stimulation-evoked dopamine release and
half-life following the drug challenge (either nomifensine, fluoxetine, or desipramine)
were expressed as mean percent change relative to the pre-drug baseline response
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(100%). Dependent measures used to quantify aspects of dopamine transmission
included: baseline (pre-drug) dopamine release, dopamine half-life, dopamine
autoreceptor-mediated inhibition, overall dopamine supply, and changes in dopamine
release and half-life following uptake blockade (via systemic nomifensine, fluoxetine, or
desipramine). An analysis of variance (ANOVA) was used to compare the dependent
measures of dopamine transmission between brain areas (striatum, NAc, amygdala, and
mPFC). Tukey’s HSD post hoc tests were used to examine significant group differences
indicated by p < .05.
Histology
At conclusion of amperometric recordings, an iron deposit was formed in brain
sites by passing a direct anodic current (100 µAmps for 10 sec) through the stimulating
electrode, and mice were euthanized with a 0.25 ml intracardial injection of urethane
(0.345 g/ml). Brains were removed, immersed in 10% buffered formalin containing 0.1%
potassium ferricyanide (which causes a redox reaction at the stimulation site resulting in
a Prussian blue spot), and then stored in 30% sucrose/10% formalin solution for at least 1
week prior to sectioning. Using a cryostat at -20°C, 30 µm coronal sections were sliced,
and electrode placements were determined under a light microscope and recorded on
representative coronal diagrams (Paxinos & Franklin, 2001).
Drugs
Urethane (U2500), nomifensine (N1530), fluoxetine (F132), desipramine
(D3900), and dopamine (H8502) were obtained from Sigma-Aldrich Chemical (St Louis,
MO). All chemicals, except for urethane (distilled water) and dopamine (PBS at pH 7.4),
were dissolved in saline (0.9%).
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Results
Stereotaxic placements of electrodes
The tips of the stimulating electrodes were positioned within the anatomical
boundaries of the MFB. The placements of the electrochemical recording electrode
surfaces were confined to the core of the striatum, NAc, basolateral amygdala (BLA), or
mPFC. Figure 1A-D is a depiction of the placement ranges and coordinates from bregma
(Paxinos & Franklin, 2001).

Figure 1. Representative coronal sections of the mouse brain (adapted from the atlas of
Paxinos and Franklin, 2001), with black shaded areas indicating the placements of the
(A) stimulating electrodes in the medial forebrain bundle (MFB) and amperometric
recording electrodes in the (B) striatum, (B) nucleus accumbens (NAc), (C) amygdala, or
(D) medial prefrontal cortex (mPFC). Numbers correspond to mm from bregma.
Dopamine release
Significant differences in relation to the magnitude of phasic dopamine release
were observed between recording sites (F(3,52) = 12.48, p < 0.01, ɳp2 = 0.42). For these
analyses, baseline (pre-drug) responses were used (n = 14 per recording site). Post hoc
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tests revealed that the striatum (M ± SEM: 1.87 μM ± 0.46) was statistically similar to the
NAc (1.93 μM ± 0.37, p = 0.99), but both the striatum and NAc had significantly greater
dopamine release than the amygdala (0.12 μM ± 0.02, p < 0.01 for both comparisons) and
mPFC (0.05 μM ± 0.02, p < 0.01 for both comparisons) (see Figure 2). No differences in
dopamine release were observed between the amygdala and mPFC (p = 0.99).

Figure 2. Amperometric recordings of stimulation-evoked dopamine release in the
striatum, nucleus accumbens (NAc), amygdala, or medial prefrontal cortex (mPFC). (A)
Mean (± SEM) differences were observed between brain regions. Symbols illustrate
significant differences from striatum (*), NAc (+), and amygdala (#). (B and C) Profiles
illustrate example responses from each recording site. Time zero indicates the start of the
train of 20 pulses at 50 Hz.
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Dopamine uptake
Calculating the baseline (pre-drug) dopamine half-life, i.e. the time needed for
50% decrease from the maximum evoked concentration increase to the pre-stimulus
level, allowed for comparisons of dopamine uptake rates, an indication of DAT
functioning, between brain areas. Significant differences in dopamine half-lives were
observed between recording sites (F(3,52) = 55.67, p < 0.01, ɳp2 = 0.76) (n = 14 per
recording site). Post hoc tests revealed that the half-life of dopamine release in the
striatum (M ± SEM: 0.40 sec ± 0.04) was statistically similar to that of the NAc (0.43 sec
± 0.05, p = 0.99), but both the striatum and NAc had significantly faster dopamine halflives than the amygdala (0.86 sec ± 0.12, p = 0.02 and 0.04, respectively) and mPFC
(2.12 sec ± 0.17, p < 0.01 for both comparisons). The amygdala also had a significantly
faster dopamine half-life than the mPFC (p < 0.01) (see Figure 3A). Reduced, or smaller,
dopamine half-lives indicate more effective DAT functioning.
Available dopamine supply
A 3-min continuous stimulation completely depleted dopamine release at each
site. Quantification of dopamine release during this depletion provides a measure of the
available dopamine neuronal reserve (Fielding et al., 2013). Significant differences in
dopamine supply were observed between recording sites (F(3,15) = 5.54, p = 0.01) (n = 4-5
per recording site). The striatum (M ± SEM: 11070 μM ± 1373) displayed dopamine
supply levels statistically similar to the NAc (8284 μM ± 1249, p = 0.49) but significantly
greater than that of the amygdala (5096 ± 1628 μM, p = 0.03) and mPFC (4004 μM ±
NAc and amygdala or mPFC (p = 0.33 and 0.13, respectively) or between the amygdala
and mPFC (p = 0.93).
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Figure 3. Specific aspects of dopamine transmission in the striatum, nucleus accumbens
(NAc), amygdala, or medial prefrontal cortex (mPFC). Mean (± SEM) differences in (A)
dopamine half-life, i.e. the time required for 50% decrease from the maximum evoked
release to the prestimulus baseline level, (B) available dopamine supply, and (C)
autoreceptor sensitivity were observed between brain regions. Symbols illustrate
significant differences from striatum (*), NAc (+), and amygdala (#).
924, p = 0.01) (see Figure 3B). No significant differences were observed between the
Dopamine autoreceptor functioning
Autoreceptor-mediated inhibition of evoked dopamine release was expressed in
terms of the percentage change between test stimulations for each set of conditioning
pulses or pre-pulses (n = 6 per recording site). Greater % change of the second test
stimulation relative to the first test stimulation indicates more efficient or more sensitive
autoreceptors. As the number of pre-pulses increases, the amount of dopamine released
by those pulses also increases, leading to more autoreceptor-mediated inhibition of
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subsequent dopamine release. With 0 pre-pulses, the test stimulations were separated by
a sufficient amount of time that no differences were seen between the test stimulations
(F(3,20) = 0.40, p = 0.75, ɳp2 = 0.07); indicating the autoreceptors were not activated.
Following 1 pre-pulse, the ANOVA indicated significant differences in autoreceptor
inhibition levels (F(3,20) = 3.29, p = 0.04, ɳp2 = 0.39); however, Tukey’s HSD post hoc
tests, which are known for being conservative in an attempt to control for the overall
alpha level, revealed no significant differences between specific recording sites.
Dopamine autoreceptors in the striatum and NAc functioned at a statistically
similar level following all pre-pulse levels (with the p value for ANOVA and post hoc
analyses set at 0.05). Figure 3C exhibits M ± SEM for each group. At 5 pre-pulses, the
autoreceptors in the amygdala were more active, leading to greater dopamine inhibition
compared to those in the striatum and NAc, and this pattern continued through the
remaining autoreceptor tests (10, 20, and 40 pre-pulses). At 10 pre-pulses, autoreceptormediated inhibition was greater in the mPFC compared to the striatum, and at 20 and 40
pre-pulses autoreceptor-mediated inhibition was greater in the mPFC compared to both
the striatum and NAc. Dopamine autoreceptors in the amygala and mPFC functioned at a
statistically similar level following all pre-pulse levels.
Pharmacological uptake blockade
During amperometric recordings of dopamine transmission, mice were given a
drug challenge of either the serotonin uptake blocker fluoxetine (n = 4 per recording site),
or the norepinephrine uptake blocker desipramine (n = 4 per recording site), the
dopamine uptake blocker nomifensine (n = 6 per recording site), or saline (vehicle) (n = 4
per recording site). Changes in peak release and dopamine half-life 20 min post injection
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were converted into percent change with baseline (pre-drug) responses being 100% (see
Figure 4).

Figure 4. Amperometric recordings of stimulation-evoked dopamine release in the
striatum, nucleus accumbens (NAc), amygdala, or medial prefrontal cortex (mPFC) 20
min following an intraperitoneal drug challenge of either saline (control), fluoxetine
(serotonin reuptake blocker), desipramine (norepinephrine reuptake blocker), or
nomifensine (dopamine reuptake blocker). (A) Nomifensine significantly increased mean
(± SEM) percent changes in dopamine release relative to saline in the striatum and NAc.
(B) Nomifensine significantly increased mean (± SEM) percent changes in dopamine
half-life relative to saline in all brain sites. * indicates significant difference from saline.

In the striatum, systemic administration of these uptake blockers significantly
altered percent change in dopamine release (F(3,14) = 7.29, p < 0.01, ɳp2 = 0.61) and
dopamine half-life (F(3,14) = 14.84, p < 0.01, ɳp2 = 0.76). Specifically, nomifensine (M ±
SEM: 248% ± 45) significantly increased dopamine release in the striatum relative to
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saline (96% ± 3, p = 0.02). Percent change in release following fluoxetine (93% ± 5) and
desipramine (88% ± 4) were statistically similar to saline (p = 1.00 and 0.99,
respectively). Regarding drug effects on dopamine half-lives in the striatum,
nomifensine (377% ± 56) significantly increased dopamine’s time in the synapse
compared to the effect of saline (101% ± 6, p < 0.01), while administration of fluoxetine
(102% ± 4) and desipramine (101% ± 1) again made no difference relative to saline (p =
1.00 for both comparisons).
In the NAc, similarly to that of the striatum, differences in percent change in
dopamine release (F(3,14) = 16.56, p < 0.01, ɳp2 = 0.78) and dopamine half-life (F(3,14) =
34.48, p < 0.01, ɳp2 = 0.88) were observed following the systemic drug challenge.
Specifically, nomifensine (329% ± 45) significantly increased dopamine release in the
NAc relative to saline (91% ± 8, p < 0.01), but release changes following fluoxetine (94%
± 5) and desipramine (85% ± 3) were statistically similar to saline (p = 1.00 for both
comparisons). Regarding drug effects on dopamine half-lives in the NAc, nomifensine
(450% ± 46) significantly increased dopamine’s time in the synapse compared to the
effect of saline (102% ± 4, p < 0.01), while administration of fluoxetine (100% ± 6) and
desipramine (101% ± 2) again made no difference relative to saline (p = 1.00 for both
comparisons).
In the amygdala, systemic administration of these uptake blockers had no
significant effect on percent change in dopamine release (F(3,14) = 0.27, p = 0.85, ɳp2 =
0.05) but did significantly affect dopamine half-lives (F(3,14) = 52.89, p < 0.01, ɳp2 =
0.92). Nomifensine (235% ± 12) significantly increased the dopamine half-life in the
amygdala compared to saline (104% ± 6, p < 0.01), while neither fluoxetine (106% ± 6)
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nor desipramine (103% ± 6) altered uptake kinetics relative to the saline control (p = 1.00
for both comparisons).
In the mPFC, similar to findings in the amygdala, no differences in percent
change in release were observed following the drug challenge (F(3,13) = 0.74, p = 0.55, ɳp2
= 0.15), but differences in percent change in dopamine half-lives were found (F(3,13) =
3.67, p = 0.04, ɳp2 = 0.46). The increase in dopamine half-life seen following
nomifensine (184% ± 29) approached statistical significance compared to the effect of
saline (102% ± 16, p = 0.053), while administration of fluoxetine (107% ± 6) and
desipramine (129% ± 16) clearly made no difference in the uptake of dopamine relative
to saline (p = 0.99 and 0.79, respectively).
In all recording sites, systemic administration of the dopamine uptake blocker
nomifensine altered either percent change in dopamine release and/or dopamine half-life
relative to saline administration, while neither the serotonin uptake blocker fluoxetine nor
the norepinephrine uptake blocker desipramine altered stimulation-evoked responses.
The results of these pharmacological manipulations indicate the measured oxidation
current changes during amperometric recordings correspond to dopamine efflux
(Mittleman et al., 2011; Tye et al., 2013).
Importantly, the recording sites responded differently to nomifensine regarding
the degree to which dopamine release (F(3,20) = 11.01, p < 0.01, ɳp2 = 0.62) and dopamine
half-life (F(3,20) = 10.68, p < 0.01, ɳp2 = 0.62) were affected. Regarding percent change in
dopamine release following nomifensine, post hoc tests revealed that the striatum
responded statistically similarly to the NAc (p = 0.37), while nomifensine increased
dopamine release more significantly in both the striatum and NAc relative to the
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amygdala (p = 0.04 and 0.01, respectively) and mPFC (p = 0.02 and 0.01, respectively).
No differences in percent change in dopamine release were observed between the
amygdala and mPFC following nomifensine (p = 0.99). Regarding percent change in
dopamine half-life, post hoc tests revealed that the striatum responded statistically
similarly to the NAc (p = 0.60) and amygdala (p = 0.09) but to a greater degree than the
mPFC (p < 0.01). The NAc, however, responded significantly greater, meaning
nomifensine made a larger impact on dopamine half-life, compared to the amygdala and
mPFC (p < 0.01 for both comparisons). No differences were found in percent change in
dopamine half-life following nomifensine (p = 0.54) between the amygdala and mPFC.
Discussion
Many lines of evidence support that midbrain dopamine neurons do not subserve
a single function, but drive multiple functions including motor movements, reward,
attention, anxiety, and decision-making. These differing behavioral processes emerge
from heterogeneous variations in uptake and release sites at midbrain dopamine afferents,
which lead to site-specific differences in dopamine concentrations during synchronous
phasic firing (Venton et al., 2003). Altered profiles of dopamine transmission can be seen
in disorders such as Parkinson’s disease, addiction, ADHD, and schizophrenia (Davis &
Khan, 1991; Dougherty et al., 1999; Kish, Shannak, & Hornykiewicz, 1988). The current
paper systematically examined specific aspects of dopamine transmission in 4 brain
regions, the dorsal striatum, NAc, amygdala, and mPFC in healthy mice. All of these
sites are known to be regulated to a large degree by dopamine and have shown
pathologies in above-mentioned disorders. Dopamine operates at the synapse on the
order of milliseconds, and the magnitude and timing of phasic release is critical for
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behavioral conditioning (Tsai et al., 2009). Thus, in vivo fixed potential amperometry is a
highly suitable technique for these measurements due to its high temporal resolution.
Results from the current study suggest distinct similarities in phasic signaling between
the striatum and NAc, and separately the amygdala and mPFC.
Dopamine release
Dopamine release was quantified as a function of peak height following electrical
stimulation of the MFB. The present findings show that even with a consistent electrical
stimulation of the dopamine axons themselves, the magnitude of dopamine release is not
equivalent across all projected brain regions. The striatum and NAc share similar
dopamine release concentrations, which are roughly 10-fold and 37-fold higher than that
of the amygdala and mPFC, respectively. Similarly proportioned differences in phasic
dopamine release have been found between these brain regions using fast scan cyclic
voltammetry (Garris & Wightman, 1994). These findings are not surprising as the
striatum and NAc are more densely innervated by dopamine axons than the amygdala and
mPFC (Doucet, Descarries, & Garcia, 1986; Descarries, Lemay, Doucet, & Berger,
1987). Extracellular neurotransmitter concentrations from synaptic release are regulated
by the rate of dopamine uptake, capacity of neuronal reserves, and autoreceptor
functioning (Nicholson, 1995; Pothos, Davila, & Sulzer, 1998; Roth, 1984); these factors
also likely contribute to the observed dopamine release differences in these brain sites.
Dopamine uptake
Quantification of stimulation-evoked dopamine half-life, i.e. the time for 50%
decrease from the response peak to the pre-stimulus baseline level, allowed for
comparisons of dopamine uptake rates, an indication of DAT functioning, in each
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examined brain area. DATs help to regulate the spatiotemporal activity of dopamine in
the synaptic space by swiftly returning the molecule to the presynaptic terminal and are
common targets of drugs of abuse such as cocaine and amphetamine (Giros et al, 1996).
Continuous amperometry has previously been used to examine dopamine activity in mice
lacking the dopamine transporter, finding the half-life to be two orders of magnitude
greater and diffusion distance ten times higher than in wildtypes (Benoit-Marand, Jaber,
& Gonon, 2000). The current experiment found the striatum and NAc to have similarly
fast dopamine half-lives, while those in the amygdala and mPFC were 2 and 5 folds
longer, respectively. These clearance rates correspond to high densities of DAT in the
striatum and NAc compared to the amygdala and mPFC (Aggarwal & Wickens, 2011;
Sesack, Hawrylak, Matus, Guido, & Levey, 1998). Similar uptake profiles have been
found using FSCV, leading to the conclusion that dopamine transmission in the striatum
and NAc are more uptake-dominated while that of the amygdala and mPFC are more
release-dominated (Garris & Wightman, 1994; Rice & Cragg, 2008; Stamford, Kruk,
Palij, & Millar, 1988). These findings suggest that dopamine transmission in the
amygdala and mPFC has the potential to diffuse further distances than that of the striatum
and NAc. The median dopamine diffusion distance can be estimated from the equation
(Dt1/2)1/2 (Garris & Wightman, 1994; Lu, Peters, & Michael, 1998), where D is the
diffusion coefficient of dopamine in the extracellular space and t1/2 is the measured halflife of stimulation-evoked dopamine. Using the value 2.4 x 10-6 cm2/s for D (Nicholson
& Rice, 1991) and quantified dopamine half-lives from the present study (see Figure 3A),
the calculated mean diffusion distance of dopamine molecules in each brain area is as
follows: 9.8 um in the striatum, 10.1 um in the NAc, 14.4 um in the amygdala, and 22.56
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um in the mPFC. These numbers are interesting for comparisons between brain sites but
may not reflect absolute diffusion distances given that the diffusion coefficient used
above was quantified from dopamine in extracellular striatal regions (Nicholson & Rice,
1991). Tortuosity, a measure of the extent to which diffusing particles are hindered by
the presence of obstructions (in the form of cells or their extensions), is a major
component of the equation defining the diffusion coefficient and may differ between
these brain sites (Nicholson & Phillips, 1981; Pereira, Oliveira, & Rosado, 2006).
DATs are typically depicted as clearance mechanisms for dopamine at the
synapse to restrict the amount of spillover and active synaptic lifetime of dopamine, thus
serving as a limiting factor for point-to-point synaptic contacts (Ciliax et al., 1995). A
more accurate depiction of the role of DATs is emerging, highlighting their critical role
in influencing the 3-dimensional sphere of diffusion beyond the synaptic release site.
Reduced DAT functioning leads to greater diffusion distances and a greater sphere of
influence through volume transmission. In contrast to point-to-point synaptic contacts,
volume transmission provides a communication mode that is temporally slower, broader
in anatomical reach, and more suited to modulatory/tuning functions. Sesack and
colleagues (1998) suggested that the elongated extracellular diffusion in the prelimbic
PFC results from a shortage of DATs in mesorcortical dopamine axons, as well as DATs
distributed further from the synaptic release site. Our results also support computational
models which state that slow reverberatory dynamics, operating on a timescale up to
seconds, are characteristic of mPFC microcircuits that underly working memory and
decision-making computations, with dopamine serving a well-recognized role in these
processes (Shephard & Grillner, 2018; Wang, 2006). On the contrary, the striatal areas
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have more restricted axonal distributions of DATs, which may account for a more
confined diffusive outreach to postsynaptic receptors (Cragg & Rice, 2004). The results
of the present study indicate that dopamine uptake rates in the amygdala fall between
those of the striatal regions and mPFC. Extending interpretations of DAT properties and
diffusion distances to dopamine transmission in the amygdala suggests brain alterations
related to fear, anxiety, memory storage, and other emotional processing may be longer
lasting and potentially more impactful than the rapid, movement and reward-related tasks
performed by the striatum and nucleus accumbens (for review see Schultz et al., 2007).
Dopamine supply
In vivo research shows the extracellular dopamine concentration levels are clearly
increased when DAT blockers or other dopamine agonists are administered (Lester,
Rogers, & Blaha, 2010; Robinson & Camp, 1990). This suggests that each dopamine
terminal has a reserve of transmitter available for release when challenged
environmentally or experimentally, via pharmaceuticals or electrical stimulation (Pothos,
Davila, & Sulzer, 1998; Willuhn, Burgeno, Groblewski, & Phillips, 2014). The differing
degrees of dopamine release seen in the striatum, NAc, amygdala, and mPFC, may be
due, in part, to different capacities of neuronal dopamine reserves in these regions. The
present study incorporated an established means of quantifying available dopamine
supply in vivo (Fielding et al., 2013). A continuous stimulation (50 Hz) lasting 3 min
was applied to the MFB during dopamine recordings in each brain site. The striatum and
NAc both have a similar, substantial reserve of dopamine available for release, while the
amygdala and mPFC have also have similar levels of available dopamine supply but
roughly half that of the striatal areas. Again, this finding likely relates to the number of

36

dopamine axons innervating these brain regions (Doucet, Descarries, & Garcia, 1986;
Descarries, Lemay, Doucet, & Berger, 1987). A relatively small reserve of available
dopamine may have driven these systems to use the neurotransmitter more efficiently, for
instance lower release concentrations with longer dopamine half-lives and increased
diffusion distances, as a way of preserving energy and resources (Attwell & Gibb, 2005).
Of course, this phenomenon may be flipped or even bidirectional, meaning reduced
release concentrations and longer half-lives may also influence dopamine synthesis and
supply levels. Either way, maximum stimulations of the MFB have varying effects on
these brain sites.
Dopamine autoreceptor functioning
Presynaptic inhibition allows for neurons to modulate their own neurotransmitter
release through the function of neurotransmitter-specific autoreceptors, which in vivo
have been shown to be activated by stimulation-evoked dopamine overflow (Dugast et al,
1997; Stark et al., 1989). In vivo, the onset of D2 inhibition is maximal between 150 and
300 ms after the end of the initial conditioning stimulation (Benoit-Marand, Borrelli, &
Gonan, 2001). D2 receptors are found in high density in the striatum and NAc, and to a
lower extent in the amygdala and mPFC (Bouthenet et al., 1991; Ford, 2014; MeadorWoodruff et al., 1989). The current study examined autoreceptor sensitivity in the
striatum, NAc, amygdala, and mPFC by using five sets of conditioning pulses or prepulses (1, 5, 10, 20, and 40 pp), delivered 300ms prior to the second test stimulation (T2).
T2 was then compared to an identical prior stimulation (T1) which did not follow prepulses. Low-to-high autoreceptor sensitivity is indicated by low-to-high percent
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inhibition of evoked dopamine efflux, such that high sensitivity would result in a lower
amplitude of T2 relative to T1.
During the 0 or 1 pre-pulse train, all sites exhibited the same level of dopamine
inhibition, which was neglible at that point; however, as the number of pre-pulses
increased the amygdala and mPFC (starting at 5 and 10 pre-pulses, respectively) began to
exhibit greater levels of inhibition or higher autoreceptor sensitivity when compared to
the striatum and NAc. This pattern remained statistically significant throughout the test.
The greatest amount of autoreceptor-mediated inhibition was seen at 40 pre-pulses, with
the inhibition level at the amygdala and mPFC being nearly double that of the striatum
and NAc. Given that the present study also showed that the amygdala and mPFC have
nearly half the dopamine supply compared to the striatal areas, more sensitive
autoreceptors may be another frugal mechanism to preserve energy and resources.
Autoreceptors in the amygdala and mPFC may also help account for the reduced DAT
functioning in these regions. Studies have shown that following chronic dopamine
agonism, the D2 autoreceptors in DAT knockout mice become supersensitive (Jones et
al., 1999; King et al., 1999). More intensive autoinhibition may be a hallmark of systems
with less efficient uptake, since these types of neural schemes tend to entail a greater
sphere of influence and longer duration of dopamine in the synaptic space.
Dopamine uptake blockade
Many drugs, both illicit (such as cocaine and methamphetamine) and prescribed
(such as Ritalin and Adderall), act by blocking dopamine uptake, thereby increasing and
prolonging the effect of dopamine in the extracellular space. Dopamine transmission in
the striatum and NAc are the most highly studied brain regions for these particular drugs
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due to the known influence of these brain areas on reward, addiction, and attention
(Church, Justice, & Byrd, 1987; Schultz, 1998; Volkow et al., 1997). Indeed, results
obtained in the present study showed that the dopamine uptake blocker nomifensine
increased the magnitude and half-life of dopamine efflux in these regions. Findings such
as these have led to the popular notion that drugs of abuse commandeer the brain’s
natural reward system during the addictive process (Kauer & Malenka, 2007).
Accordingly, prevention of dopamine uptake also increases diffusion distances, leading to
activation of far more dopamine receptors at distal sites and alteration the normal balance
of tonic and phasic dopamine activity (Venton et al., 2003; Sulzer, 2011). These drugs
are not spatially restricted in the brain when administered and, therefore, are potentially
influential wherever DATs are located.
The present study found that the dopamine uptake blocker nomifensine had no
effect on the magnitude of dopamine release in the amygdala or mPFC. Similar findings
have been reported when using FSCV, leading researchers to conclude that DAT
inhibitors may not be as influential in these brain areas (Cass & Gerhardt, 1995; Garris,
& Wightman, 1995; Jones, Garris, Kilts, & Wightman, 1995; Mundorf, Joseph, Austin,
Caron, & Wightman, 2001). Given that DAT inhibitors specifically target proteins
regulating dopamine uptake kinetics, but not necessarily release, analysis of dopamine
half-life is considered to provide a more appropriate measure. In the present study,
systemic injection of the dopamine uptake blocker nomifensine nearly doubled the time
required for dopamine clearance in both the amygdala and mPFC, suggesting such drugs
are also influential in these brain regions although to a lesser degree than in the striatum
and NAc. The vast differences between the effect of DAT inhibition on dopamine
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release and half-life in striatal and corticolimbic regions is likely again related to terminal
density of DAT (Garris & Whiteman, 1994), and also the relative affinities of DAT in
each of these regions. Specifically, DAT in the striatum and NAc have a relatively high
affinity (Km of ~0.2 uM and a Vmax of 3.8 uM/s and 2.4 uM/s, respectively), while that
of the amygdala has been shown to be lower (Km of 0.6 uM and Vmax of 0.49
microM/s) (Horn, 1990; Jones, Garris, Kilts, & Wightman, 1995). As another
mechanism to consider, norepinephrine transporter (NET) levels are higher in the PFC,
relative to DATs, with the opposite being true in subcortical regions (Morón,
Brockington, Wise, Rocha, & Hope, 2002; Sesack, Hawrylak, Matus, Guido, & Levey,
1998). Further, dopamine has been shown to have a higher affinity for the NET than the
DAT (Morón, Brockington, Wise, Rocha, & Hope, 2002).
Overall, these findings and others suggest that uptake blockers have spatially
heterogeneous effects in different regions of the brain. These findings provide
implications for education on the use of recreational and medicinal drugs which affect
DAT functioning and, consequentially, extracellular dopamine levels. For example,
increased dopamine activity in the amygdala can lead to increased occurrence of anxietyrelated behaviors (Abercrombie, Keefe, DiFrischia, & Zigmond, 1989; Borowski &
Kokkindis, 1998; de la Mora et al., 2010), potentially by dampening the regulatory
control of PFC inputs to the amygdala (Diaz et al., 2011). Furthermore, excessive
dopamine in the mPFC can result in poorer performance on cognitive tasks related to
working memory and attention (Mattay et al. 2003; Zahrt, Taylor, Mathew, & Arnsten,
1997). Thus, an understanding of phasic dopamine manipulations in these regions is
critical for symptom control.
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Conclusions
The present study found distinct differences in phasic dopamine dynamics in 4
prominent output sites for the nigrostriatal and mesolimbic dopamine pathways: the
dorsal striatum, NAc, amygdala, and mPFC. Specifically, the striatum and NAc had
increased stimulation-evoked phasic dopamine release, faster dopamine uptake (leading
to less dopamine diffusion), weaker autoreceptor functioning, greater supply levels of
available dopamine, and increased dopaminergic responses to DAT blockade compared
to the amygdala and mPFC. Previous studies have measured dopamine release and
uptake differences in these sites, but to our knowledge this paper may be the first to
systematically quantify these properties while concurrently examining autoreceptor
functioning, dopamine supply levels, and the effect of uptake blockers in mice using a
consistent electrochemical technique with high temporal resolution. Our findings
revealed paired similarities in phasic dopamine dynamics between the striatum and NAc
and between the amygdala and mPFC. Functionally, these brain sites influence a range
of different behaviors; however, anatomically, the striatum and NAc exist along a
continuum with the NAc often referred to as the ventral striatum. Other researchers have
likewise proposed portions of the amygdala to be a neural extension of the frontal cortex,
rather than an independent functional unit (LeDoux, 2007; Swanson & Petrovich, 1998).
Anatomical similarities also include the number of dopaminergic projections to these
regions, with the striatum and NAc being more densely innervated by dopamine
terminals than the amygdala and mPFC (Doucet, Descarries, & Garcia, 1986; Descarries,
Lemay, Doucet, & Berger, 1987). Overall, these findings indicate that phasic dopamine
may have different modes of communications between striatal and corticolimbic regions,
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with the first being profuse in concentration, rapid, and synaptically confined, and the
second being more restricted in concentration but longer lasting and spatially dispersed.
Understanding the various aspects of regional differences in phasic dopamine
transmission may be useful for predicting and manipulating the effects of drugs on
dopamine dependent behaviors.
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CHAPTER 3: CEREBELLAR DOPAMINERGIC SIGNALING IN THE
DORSOMEDIAL STRIATUM OF FRAGILE-X MICE: SIGNIFICANCE TO
AUTISM SPECTRUM DISORDERS
Introduction
The mammalian brain has evolved into an electrochemical network that functions
to achieve the goals best suited for an organism’s survival and to avoid those it deems
most detrimental. Within this network, all external and internal sensory information is
processed and integrated, which contribute to a person’s overall health and mental
functioning in the environment. A disruption in this sensory integration is evident in
people diagnosed with autism spectrum disorders (ASD). Patients with autism show
deficits in recognizing common social cues in the environment, processing and retrieving
items from internal memory, and implementing these aspects to plan and perform
complex motor functions, which drive reward-seeking behavior.
Two major brain areas are involved in the coordination of sensory input and the
development of motor processes: the cerebellum and the basal ganglia. The cerebellum—
controller of the spatiotemporal aspects of movement—is pathologically developed in
ASD with abnormal projections stemming to multiple nuclei throughout the brain,
eventually producing attenuated neurotransmitter release in the frontal lobe. A
subdivision of the major input station of the basal ganglia—the dorsomedial striatum—
receives inputs from nearly all areas of the cerebral cortex to assemble goal-directed
behavior and is a likely candidate for dysfunction in autism. However, little research has
examined if the cerebellum has modulatory connections with this region. The current
study uses a systems neuroscience approach to investigate the notion that the cerebellum
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has projections to the nigrostriatal DA network, leading to cognitive and behavioral
deficits in ASD through signaling dysfunction in the dorsomedial striatum.
Involvement of the Cerebellum in ASD
The specific etiology of autism remains unknown. However, investigations have
linked genetic proclivities, viral infections, toxins, and aberrant neural development to the
pathologies of ASD (Rogers, Mckimm, et al., 2013). Each of these pathologies has
emerged to produce a similar finding of changes among the substructure of the
cerebellum. Within the cerebellum of the autistic brain, the most common
neuropathology observed is loss of cortical Purkinje cells and hypoplasia (Bauman, 1991;
Courchesne, Yeung-Courchesne, Hesselink, & Jerningan, 1988; Courchesne, Lincoln,
Haas, & Schreibman, 1994; Courchesne, 1997; DiCicco-Bloom et al., 2006; Palmen, van
Engeland, Hof, & Schmitz, 2004). These neurons appear to be necessary for sustaining
coordination and homeostasis of the electrochemical communication throughout many
systems in the brain.
Abnormal changes in the cerebellum or damage of these Purkinje cells commonly
leads to a disruption in their profound signaling ability and can cause alterations in motor
skills (Middleton & Strick, 2000; Thach, 1998), but how does this explain the cognitive
deficits seen in autism? In ASD, level of motor skills has shown to be predictive of levels
of autistic symptoms in later life (Sutera et al., 2007), suggesting an interrelation between
motor and cognitive deficiencies. Modulation of cerebellar Purkinje cell output may serve
as the starting point of this interrelation (Ciesielski & Knight, 1994), but locating affected
downstream pathways and targets that modulate the motor and cognitive processes is an
important link to understanding autism. Knowledge of these pathways may help to
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explain the deficits of memory, executive functioning and planning seen in patients with
ASD. Comprehension of the Purkinje cell’s systematic ability to process, encode, and
spread information throughout the brain is paramount for understanding the cerebellum’s
role in controlling the integration of these motor and cognitive signals.
Information Processing in Purkinje Cells
Maintaining optimal functioning of Purkinje cells is proving to be critical for
proper activity of many neural systems in the brain. The sensory association cortex and
motor association cortex of the parietal and frontal lobes, respectively, have projections
to the cerebellum that function to integrate and sharpen movement. These pathways send
information to the mossy fibers (MF) of neurons in the pontine nuclei, which in turn relay
inputs in a contralateral manner to the cerebellar cortex. These MFs form a small
convergence of synapses on granule cells, which are the most abundant type of neuron in
the human brain (Wechsler-Reva & Scott, 1999). Granule cells then recode information
obtained from MFs and transmit a complete contextual account of MF activity through
excitatory signals of parallel fibers, minimizing destructive interference and facilitating
learning in Purkinje cells, which stimulates further signal output (Philipona & Oliver,
2004). Input from the cerebral cortex to the cerebellum is attributable to various types of
nuclei (visual, spatial, premotor, motor), but complex synchronization of information
allows Purkinje cells to provide the sole source of output from the cerebellar cortex, via
activity on the deep cerebellar nuclei (Voogd & Glickstein, 1998).
Due to the GABAergic (γ-aminobutyric acid containing) nature of these neurons,
Purkinje cells use inhibition to shape the spatiotemporal patterns of electrical and
chemical signaling throughout the brain (Huang, 2007). Investigations of feed-forward
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neural networks suggest that a single Purkinje cell can retain up to 40,000 input-output
associations (Brunel, Hakim, Isope, Nadal, & Barbour, 2004). This multiplicity of
interactions allows for continuous error recognition and correction of sensory stimuli,
which produces fine-tuned movement best suited for the brain’s current environment.
Cognitive and Behavioral Deficiencies in Autism
The frontal lobe is known to be involved in problem solving, executive
functioning, self-awareness, and other aspects of social behavior (Chayer & Freedman,
2001). Patients with ASD exhibit many deficits in these areas of mental processing, and
the frontal cortex of children with autism tends to be abnormally developed. Specifically,
the medial and dorsolateral regions are sites of significant overgrowth when compared to
controls (Carper & Courschesne, 2005), and when performing mental rotation tasks to
assess competence in working memory and executive functioning, children with ASD
revealed significantly less cortical activation in the prefrontal area (Silk et al., 2006). It is
important to note that the degree of cerebellar abnormality in patients with autism is
correlated with this increase in growth (Carper & Courschesne, 2005). Palesi et al. (2013)
found that cerebellar hemispheres are connected via the ventrolateral thalamus with
contralateral associative (prefrontal, parietal, temporal cortices) areas in the brain,
supporting the notion that deficits in Purkinje cells may contribute simultaneously to
malfunctions in motor skills and cognitive processes in ASD.
Recent in vivo neurochemical recordings of mice strains used to model autism
show that Purkinje cells regulate dopaminergic activity via projections from the DN to
cognitive centers in the brain and also exhibit a reorganization of mediating neuronal
pathways. Mittleman, Goldowitz, Heck, and Blaha (2008) used DN electrical stimulation
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to evoke DA efflux in the medial prefrontal cortex (mPFC) of Lurcher mutant mice (a
common model of ASD with 100% loss of Purkinje cells within the first 4 weeks of life)
and compared their responses to wildtype mice that served as controls. The Lurcher
mutants exhibited attenuation in mPFC DA release when compared to controls. This
suggests that developmental loss of Purkinje cells, similar to that of ASD, can lead to a
disruption in mPFC DA modulation. However, the specific nuclei involved in this
disruption remain unclear.
Rogers, Dickson, et al. (2013) followed this pursuit by comparing cerebellar
modulation of dopaminergic mPFC release in Lurchers and a mouse model of Fragile-X
syndrome (FMR1 KO mice), which unveiled a reorganization of mediating neuronal
pathways projecting to the mPFC. In this study, infusions of the sodium channel blocker
lidocaine or the glutamate receptor antagonist kynurenate were used to inactivate
dopaminergic and glutamatergic neuronal bodies (ventral tegmental area, thalamic
mediodorsal, or thalamic ventrolateral), respectively, to compare functional adaptations
of cerebello-cortico circuitry associated with abnormalities in cerebellar functioning. An
attenuation of cerebellar-mPFC DA release was found in both mutant mice strains, along
with a shift in strength of dopamine signal modulation towards the thalamic ventrolateral
nuclei (ThN vl), away from the ventral tegmental pathway, while inactivation of the
mediodorsal thalamic nuclei (ThN md) did not alter DA release significantly in either
strain. A shift in modulatory strength towards the ThN vl is an important finding to note
due to its known projections to the dorsomedial striatum (Jayaraman, 1985).
Mutant mice strains show neuronal pathology similar to those seen in autism, and
behavioral deficits in these mice have also been found to correlate with those seen in
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autism. Atypical behavior in children with autism may manifest as alterations in eating,
increased aggression, and abnormal sleep patterns; with high exhibition of atypical
behaviors negatively correlating with social skills and nonverbal IQ (Dominick, Davis,
Lainhart, Tager-Flusberg, & Folstein, 2007). Repetitive hand and foot movements are
also often seen in individuals diagnosed with ASD in addition to a reported lack of
coordinated balance (Dowell, Mahone, & Mostofsky, 2009; Freitag, Kleser, Schneider, &
von Gontard 2007). As with most aspects of abnormal performance, neurochemical
malfunction is expected to prevail as a source of these deviations from typical behavioral
functioning. Dickson et al. (2010) examined Lurcher chimeras, which have a variable
loss of Purkinje cells, to determine if neuronal degradation had an effect on behavioral
aspects of brain functioning. They found a negative correlation between executive
functions, working memory, and repetitive behavior with the number of Purkinje cells.
This suggests that the animal models used were efficacious in mimicking the
symptomology seen in autism. However, for the current study we needed to ensure that
the mouse strain used was the ideal candidate for assessing detriments in neural
pathways. Although the Lurcher mutants were a potential choice, we chose a different
strain which we believe is more applicable. This is discussed more fully below.
Rodent Models of Autism Spectrum Disorders
Fragile-X syndrome is the most common monogenetic cause of autism, stemming
from the silencing of the FMRP gene (Brown, 2005). FMR1 KO mice were designed to
mimic the behavioral and neural symptoms of ASD such as elongated Purkinje cell
spines, decreased cerebellar volume, learning deficiencies, and hyperactivity (Baker,
1994; Koeckoeck, 2005; Rogers et al., 2013). Although Lurcher mutant mice have

59

frequently been used to study autism, they have an autosomal dominant mutation which
causes total degeneration of cerebellar Purkinje cells within the first few weeks of life
(Vogel, Caston, Yuzaki, & Mariani, 2007). A complete loss of these cells does not
adequately parallel the cerebellar pathology seen in autism. Thus, the FMR1 KO strain
was chosen as the animal model for the current study.
Combining Experimental Approaches
The combined use of behavioral and neurochemical experiments has provided
evidence that mechanisms which govern detriments in motor skill learning and executive
performance in autism arise, at least partially, from dysfunction of cerebellar
manipulation on dopaminergic activity in the frontal lobe via the mesocortical
dopaminergic pathway (Mckimm et al., 2014; Rogers et al., 2013). Previously discussed
research also provides ample evidence to initiate a search for neurochemical deficits in
the nigrostriatal system, particularly the dorsomedial striatum, which we believe to be
directly mediated by cerebellar efferents of the DN (Figure 1). With the knowledge of a
shift in cerebellar modulatory strength toward the thalamic ventrolateral nuclei in rodent
models of autism (Lurcher, FMR1) and the known connections between this nuclei and
the striatum, it is expected that the dorsomedial striatum will exhibit abnormal DA
release.
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Figure 1. We predict that the cerebellum acts as a modulator of striatal dopamine
release. This projected system occurs via polysynaptic inputs from cerebellar nuclei to
dopamine-containing cells in the substantia nigra (SN), eventually leading to DA release
in the dorsomedial striatum. Glutamatergic pathways are shown as red lines and the
dopaminergic pathway as a green line.
Relevance of the Striatum
Modulation of the medium spiny neurons of the dorsal striatum allows for
activation and inhibition of the direct and indirect pathways within the basal ganglia
through activation of the expressed D1 and D2 receptors. The direct and indirect
pathways enable the basal ganglia to interact with the motor cortex to select proper motor
programs best suited to gain rewards and simultaneously inhibit competing motor
programs that are least beneficial in reward-seeking behavior, respectively (Kravitz &
Kreitzer, 2012).
Within the motor and cognitive loops of the basal ganglia, the dorsomedial
striatum acts not only as a subunit of the major input station, but it also has developed
connections to the associative cortex and many other neuronal sectors (hippocampus,
amygdala, prefrontal cortex, thalamus) (Graybiel, Aosaki, Flaherty, & Kimura, 1994).
This allows for control of adaptive voluntary movement and goal-directed actions, which
are known to be involved in executive functioning (Da Cunha, Gomez, & Blaha, 2012).
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Understanding the functional relationship between cerebellar pathology and the
dorsomedial striatum is pertinent to resolving symptoms seen in ASD.
Previous research has shown aberrant striatal functional connectivity with the
anterior cingulate and frontal cortex, orbitofrontal cortex, and the brain stem (Di Martino
et al., 2011). This may coincide with evidence of attenuated cerebellar modulation of DA
release in the prefrontal cortex of Lurcher mutant and Fragile-X mice, along with
alterations in modulatory DA control away from the VTA toward the thalamic pathway
(Mittleman et al., 2008; Rogers et al., 2011, 2013). In regard to the dorsomedial
striatum’s involvement in pathway alterations and attenuated DA release in the mPFC, it
is important to note that the striatum has connections with the center median,
ventrolateral and central lateral thalamic nuclei (Jayaraman, 1985). It is probable that
these pathways contribute to many of the pathologies seen in autism. Evaluation of all
evidence leads to our predicted hypothesis that mutant Fragile-X mice will show
significant decreases in the DN-stimulation evoked dopamine response within the
dorsomedial striatum in comparison to their wildtype controls.
Methods
Animals
Animals were bred and maintained at the University of Memphis in the Animal
Care Facility located in the Department of Psychology. Mice were continuously
maintained in a temperature-controlled environment (21±1 °C) on 12:12 light/dark cycle
(lights on at 0800) and were given free access to food and water. All proposed
experiments were approved by a local Institutional Animal Care and Use Committee and
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conducted in accordance with the National Institutes of Health Guidelines for the Care
and Use of Laboratory Animals.
Breeding
To produce Fragile-X experimental mice (FMR1) two phases of breeding were
required. The first stage consists of male mice hemizygous for the FMR1tm1Cgr targeted
mutation (FVB. 129P2-FMR1tm1Cgr/J, #004624) being mated with female wildtype
control mice ((FVB.129P2-Pde6b+ Tyrc-ch/AntJ, #004828). The initial offspring produced
litters composed of heterozygous females and wildtype males. The second stage consisted
of heterozygous female mice being mated with wildtype male mice to produce litters
containing both hemizygous and wildtype males. The wildtype littermates were used as
control experimental subjects.
Surgery
A total of 15 subjects were examined (9 FMR1 wildtype, 6 FMR1 mutant
knockouts). All were urethane-anesthetized (1.5 g/kg i.p.) and placed in a stereotaxic
frame. Body temperature was maintained at 36±0.5 °C with a temperature-regulated
heating pad. Fixed potential amperometry (FPA) was used with a concentric bipolar
stimulating electrode (SNE-100, Kopf Instruments), a carbon-fiber microelectrode
(dopamine recording electrode; carbon fiber 10 µm o.d., 250 µm length, Thornel Type P,
Union Carbide, Bristol, PA, USA), and an Ag/AgCl reference combination electrode. In
individual mice, the stimulating and reference electrodes were implanted ipsilateral to
one another in the right hemisphere, while the recording electrode was implanted
contralateral in the left hemisphere; with respect to bregma and dura. Using stereotaxic
coordinates in millimeter units, the stimulating electrode was lowered into the DN of the
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cerebellum (AP = -6.25, ML = 2.1, DV = -2.4) and the DA recording electrode was
implanted into the dorsomedial striatum (AP = 1.5, ML = .8, DV = 2.8).
Fixed-potential Amperometry
FPA coupled with carbon-fiber dopamine recording microelectrodes is a technique
for real-time monitoring of stimulation-evoked dopamine release. Following implantation
of all electrodes, a constant voltage of +0.8 V was applied to the recording electrode, and
an oxidation current, reflective of dopamine concentrations, was sampled continuously
(10,000 samples/s) via an electrometer (ED401 e-corder 401 and EA162 Picostat, eDAQ
Inc., Colorado Springs, CO, USA) filtered at 10 Hz low pass. A total of 100 stimulations
(monophasic 0.5 ms duration pulses at 50 Hz every 60 s) was applied to the DN (at 800
µAmps) via the stimulating electrode with use of an optical isolator and programmable
pulse generator (Iso-Flex/Master-8; AMPI, Jerusalem, Israel). As seen in Figure 2, the
recording electrode was placed in the dorsomedial striatum to monitor DA concentration.

Figure 2. A stimulating electrode was placed in the deep cerebellar nuclei (dentate
nucleus) and a carbon-fiber recording electrode monitored dopamine release in the
dorsomedial striatum.
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Histology
Immediately following each experiment, a direct current (100 µA for 10s; +5 V
for 5 s) was passed through the stimulating electrode in the DN and through the recording
electrode in the dorsomedial striatum to lesion tissue in each site. Each mouse was
euthanized with a lethal intracardial injection of urethane. Brains were removed and
preserved overnight in 10% buffered formalin containing 0.1 % potassium ferricyanide,
and then stored in 30 % sucrose/10 % formalin solution until sectioning. Brains were
sectioned on a cryostat at -30 ̊C. A Prussian blue spot indicative of the redox reaction of
ferricyanide and iron deposits labels the stimulating electrode in the dentate, and the
location of the recording probe was determined by the electrolytic lesion.
Data Analysis
DN stimulation-evoked was extracted from the amperometric current recordings
within the range of 0.2 s to 30 s post stimulation (-0.2 s through 30 s) for each of the
mutant and wildtype mice. The percent difference in overall magnitude of DA release in
the dorsomedial striatum was summed and compared for each group (KO, WT) using a
oneway between-groups analysis of variance (ANOVA). Average magnitude of DNevoked dopamine oxidation current was the dependent variable and the independent
variable was the mouse strain (KO versus WT).
Results
A total of 15 mice, 9 WT and 6 KO, were used in our analysis. Responses to
electrical stimulation were obtained 2 seconds pre-stimulation to 30 seconds poststimulation (Figure 3), and used to calculate an average DA concentration value (Figure
4) in micromoles (μM) using flow injection analysis data and FPA data for both the
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FMR1 wildtypes (M = 0.0021, SD = 0.0009, SEM = 0.0003) and the FMR1 KO groups
(M = 0.0018, SD = 0.0027, SEM = 0.0011). The two groups of mice were not found to be
different with respect to the magnitude of DA release [F(1, 13) = 4.67, p = 0.83]. These
results suggest that the cerebellum does act to modulate DA signaling in the nigrostriatal
pathway and that the neural pathologies seen in the FMR1 mutant mice do not extend to
the dorsomedial striatum in terms of DA release. However, it should be noted that
downstream output of the dorsomedial striatum was not assessed and its functioning
could be of question.

FMR1 Wildtype DA Release

0.05

Conc. Dopamine (μM)

0.04
0.03
0.02
0.01
0
-0.01
-0.02
-0.03

Time
Stimulation 1

Stimulation 2

Stimulation 3

Stimulation 4

Figure 3. Recorded magnitude of DA release in FMR1 wildtype 2 seconds prestimulation to 30 seconds post-stimulation. Concentration of neurotransmitter is shown in
micromoles (μM).

66

Comparison of Mean DA Release Between Mice Strains
0.001

Concentration in µM

0.0009
0.0008
0.0007
0.0006
0.0005

wildtype

0.0004

knockout

0.0003
0.0002
0.0001
0

Fmr 1 strain

Figure 4. Average stimulation-evoked dopamine release in Fragile-X mutants (M =
0.00183 µM) and wildtypes (M = 0.002063 µM) in micromoles. No significant
differences were found between groups.
Discussion
The aim of the current study was to determine if the cerebellum modulates the
nigrostriatal dopamine pathway in the mammalian brain, and if so, to understand if
dopaminergic transmission in the dorsomedial striatum is abnormal in ASD. Our results
support the notion of cerebellar modulation on the nigrostriatal pathway due to both mice
strains (WT, KO) exhibiting DA release when stimulated. However, we found no
significant difference in this dopaminergic release within the dorsomedial striatum
between our mutant and control mice. These results suggest that the dorsomedial striatum
is functionally regulated by the cerebellar dentate.
It would be beneficial to examine other rodent models of autism, particularly
Lurcher mutants, to determine the functionality of the dorsomedial striatum. Rogers et al.
(2013) have shown that both Lurcher and FMR1 mutant mice exhibit attenuations in
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cerebellar stimulation-evoked DA release in the mPFC with an accompanying
reorganization of neuronal pathways. A comparative analysis of a mouse strain lacking
all Purkinje cells (Lurcher) and a strain modeling Fragile-X syndrome (reduced
number/maldeveloped Purkinje cells) may provide further insights to our understanding
of the striatum’s role in this disorder (Mittleman et al., 2008). If the dorsomedial striatum
is found to be functional in Lurchers as well, researchers could then begin to search for
deficits in downstream pathways and surrounding nuclei to pinpoint likely disruptions. It
is possible that other nuclei within the basal ganglia circuitry could be subject to
dysregulation. If it is found that Lurcher mutants exhibit abnormal DA release in the
dorsomedial striatum when compared to controls, one must next search to understand
how these abnormally developed Purkinje cells in FMR1 mice are still able to signal
properly. With the brain’s highly plastic nature, this is a possibility worth examining.
This experiment additionally sought to obtain levels of DA release, but we were
unable to assess neurotransmitter binding efficacy or receptor activation. The D1 and D2
G-protein coupled receptors (D1DR, D2DR) located within the striatum are complex
proteins that are dependent upon spatiotemporal signaling. These receptors play a major
role in the inhibition network, which has shown to be deficient in neurodegenerative
diseases such as schizophrenia, addiction, and Parkinson’s (Barnett et al., 2010; Gauggel,
Rieger, & Feghoff, 2003; Koob & Volkow, 2010). When this inhibition network is
examined in individuals with high-functioning autism, the brain areas involved show
decreased activation and under-connectivity (Kana, Keller, Minshew, & Just, 2007).
Specifically, when individuals were asked to complete a response-inhibition task they
showed lower levels of synchronization within the inhibition network (anterior cingulate
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gyrus, middle cingulate gyrus, and insula) and the right middle and inferior frontal and
right inferior parietal regions. Eagle et al. (2011) used a stop-signal task and D1/D2
receptor antagonists to examine the role of the dorsomedial striatum and nucleus
accumbens core in behavioral inhibition; finding that receptors in the striatum, but not the
nucleus accumbens core act to balance behavioral inhibition. In order to further assess
the role of the dorsomedial striatum in this disorder, FMR1 mutant mice could be tested
on a behavioral inhibition measure similar to the stop-signal task. Di Martino et al. (2011)
found that the striatum has connections branching to each of the areas mentioned
(cingulate cortex, insula, parietal cortex), and in autism, connectivity has extended to
areas not seen in typically developing children. Interestingly, the striatum was found to
have hyperconnectivity to the pons and insula. If FMR1 mutant mice show decreased
behavioral inhibition when compared to controls, it may help develop an understanding
of how the D1DR and D2DR function in ASD.
The autism disconnection hypothesis has mostly been supported by findings of
decreased function of corticocortical networks, but it is becoming clear that subcortical
nuclei are a major determining factor in some of the symptoms seen in ASD. The
dorsomedial striatum, with its extensive connections throughout the brain, may act as an
intermediary waypoint which contributes much of the lowered connectivity between the
subcortical and cortical nuclei. Although the current study showed no significant findings
of DA release in this area, future behavioral assessment of rodent ASD models and
examination of other basal ganglia circuitry (nucleus accumbens, substantia nigra,
dorsolateral striatum) may reveal neural abnormalities significant to resolving
degenerative symptoms seen in ASD.
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CHAPTER 4: CEREBELLAR MODULATION OF MESOLIMBIC DOPAMINE
TRANSMISSION IS FUNCTIONALLY ASYMMETRICAL
Introduction
Cerebellar and Cerebral Networks
The bilateral cerebral and cerebellar hemispheres are asymmetrical in structure,
behavior, and function (Hu, Shen, & Zhou, 2008; Hugdahl & Davidson, 2004; Scott et
al., 2001; Toga & Thompson, 2003). No longer considered a structure primarily for
motor coordination, the cerebellum is now known to contain three distinct regions that
contribute to sensorimotor, limbic, and cognitive processes (Schmahmann & Caplan,
2006). Cerebellar and cerebral systems work in concert to sharpen the timing of these
neural operations (Heck et al., 2013; Weaver, 2005), and each cerebellar hemisphere is
connected to multiple closed-loop cortical neural networks in the contralateral cerebral
hemispheres, providing an anatomical basis for a cerebellar role in cognition (Buckner,
2013; Middleton & Strick, 1994; Schmahmann, 2016). This allows for a cerebellar
mirroring of functional specializations in the cerebrum, and accordingly, lateralized
cerebellar lesions produce cognitive deficits similar to those observed following lesions
of the contralateral cerebral cortex (Riva & Giorgi, 2000).
Functional Asymmetry in Behavior
Hemispheric specializations have long been documented within cerebrocerebellar
networks in many species including birds, rodents, and primates (Camp, Robinson, &
Becker, 1983; Walker, 1980). Clinical and preclinical studies support the association of
the left cerebral hemisphere with communication functions and the right cerebral
hemisphere with spatial reasoning (Denenberg, 1981; D’Mello & Stoodley, 2015). Due
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to contralateral connections between cerebrocerebellar systems, the cerebellar
hemispheres parallel these specializations. Correspondingly, imaging and lesion studies
in humans have found the left cerebellar hemisphere to be involved in visuo-spatial
operations (Imamizu et al., 2003; Marien, Engelborghs, Fabbro, & De Dyn, 2001; Silveri,
Misciagna, Leggio, & Molinari, 1997; Stoodley & Schmahmann, 2009), and a right
cerebellar involvement in language processes (De Smet, Paquier, Verhoeven, & Marien,
2013; Papthanassiou et al., 2000; Verly et al., 2014). Likely related to these behaviorally
based asymmetries, the bilateral hemispheres of the brain also contain lateralized
neurotransmitter systems in cortical and subcortical regions, and certain experiences have
shown to enhance this lateralization. For example, rats that were handled in their early
life showed a significant left/right asymmetry (R>L) in dopamine levels in the NAc
(Camp, Robinson, & Becker, 1984). Other studies in rats show greater concentrations of
DOPAC/DA in the right cortex and nucleus accumbens in comparison to systems in the
left hemisphere (Rosen et al., 1984). Dopaminergic lateralization may therefore be
contributing to behavioral abnormalities. For instance, increased dopamine levels in the
right prefrontal cortex of adult rats was found to be strongly correlated with anxiety
responses in the elevated plus-maze test (Andersen & Teicher, 1999). Furthermore,
researchers suggest that heterogeneous profiles of dopamine are related to handedness or
limb preference; dopamine levels tend to be greater in the NAc ipsilateral to the preferred
limb (Budlin et al., 2008). Asymmetrical structure and function in dopaminergic systems
appear to be a product of both life experiences and typical neurodevelopment.
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Cerebellar Involvement in Dopamine Asymmetry
Many neurophysiological disorders are characterized by altered profiles of
mesocorticolimbic dopaminergic transmission, such as addiction, ADHD, and
schizophrenia (Davis & Khan, 1991; Dougherty et al., 1999; Kish, Shannak, &
Hornykiewicz, 1988), and interestingly, cerebellar pathology and specifically Purkinje
cell dysfunction are being considered as substrates in these and other psychiatric
disorders (Shakiba, 2014; Fatemi, & Folsom, 2014; Wang, Kloth, & Badura, 2014). The
cerebellum exerts modulatory influence on the cerebrum via Purkinje cells and their
synaptic output on the deep cerebellar nuclei, specifically the dentate nucleus (DN),
which provides the sole output from the cerebellum to the cerebrum. Mittleman,
Goldowitz, Heck, and Blaha (2008) used DN electrical stimulation to evoke dopamine
efflux in the medial prefrontal cortex (mPFC) of Lurcher mutant mice (a common model
of autism spectrum disorder with 100% loss of Purkinje cells within the first 4 weeks of
life). The Lurcher mutants exhibited an attenuation in mPFC dopamine release compared
to controls, suggesting that developmental loss of Purkinje cells in the cerebellum, similar
to that of autism spectrum disorder, can lead to a disruption in mPFC dopamine
transmission.
Rogers et al. (2011) expanded on the research of Mittleman and colleagues by
using in vivo fixed potential amperometry (FPA) with carbon-fiber microelectrodes to
compare functional adaptations of cerebello-cortico circuitry associated with
abnormalities in cerebellar functioning. They found attenuation and reorganization of
cerebellar modulation in the mPFC dopamine release of Lurcher mutants and Fmr1 mice
(another genetic model that exhibits dysfunction or absence of Purkinje cellular influence
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in the cerebellum). The reorganization of these pathways, which originated in the DN
and concluded in the mPFC, included altered relative influence of the VTA and thalamic
nuclei, with the mutant mice showing a stronger dependence on thalamic nuclei
compared to control mice (Rogers et al., 2011). This shift in cerebellar modulation
towards the ventral lateral thalamus leads to speculation about the cerebellum’s influence
on not only the mPFC, but also the nigrostriatal and mesolimbic pathways (Di Martino et
al., 2011). The current experiment adds to the literature supporting a cerebellar role in
modulation of cerebral neurotransmission and provides evidence that dopamine
lateralization may be modulated or organized by the cerebellum.
Intertwinement of the VTA within cerebrocerebellar networks suggests that the
cerebellum is in position to modulate dopamine release not only in the mPFC but also in
the NAc, the other major projection site of the mesocorticolimbic dopamine system.
Neural fibers between the VTA and NAc constitute one of the most densely innervated
dopamine pathways in the brain (Doucet, Descarries, & Garcia, 1986; Descarries, Lemay,
Doucet, & Berger, 1987). Dopamine release in the NAc is known to be associated with
reward and motivational processes (Cohen et al., 2012; Matsumoto & Hikosaka, 2009;
Mirenowicz & Schultz, 1996; Robinson et al., 2009), and disruption to normal dopamine
processing, including hemispheric balance, can lead to a host of motor and cognitive
deficits. For example, decreased motivation and novelty seeking are related to asymmetry
of dopamine often observed in patients with Parkinson’s disease (Tomer & AharonPeretz, 2004), and individual differences in incentive motivation or sensitivity to natural
rewards in humans has been associated with increased asymmetry in dopaminergic
systems (Tomer et al., 2008).
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Specific Aims of the Experiment
Aforementioned findings highlight the importance of the functional balance in
dopamine transmission and the influence of the cerebellum on dopamine cell bodies.
Overall, the present study aimed to determine whether the cerebellum output can
stimulate NAc dopamine release as has been shown with mPFC and whether hemispheric
asymmetry occurs between these pathways. Determining if reward processes are
lateralized may have considerable application to our understanding of normal and
abnormal psychological states. The present study includes three series of tests that were
conducted to address three separate hypotheses. In the first experiment, we assessed
subcortical dopamine lateralization by quantifying NAc dopamine release in each
hemisphere elicited via stimulation of the medial forebrain bundle (MFB), which consists
of the dopaminergic axons projecting from the VTA to NAc. The second experiment
assessed cerebellar influence of NAc dopamine lateralization by comparing DN
stimulation-evoked dopamine release in both hemispheres. The DN has contralateral
glutamatergic projections to reticulotegmental nuclei (RTN) that, in turn, project to
pedunculopontine nuclei (PPT), which projects to and stimulates dopamine cell bodies in
the VTA. For this reason, the present study stimulated the DN located contralateral to the
NAc recording site (left DN stimulation with right NAc recording and vice versa)
(Bostan, Dunn, & Strick, 2010; Palesi et al., 2015). The third experiment in the present
study examined the potential cross-hemispheric influence of cerebellar DN on this
dopaminergic pathway. During contralateral DN stimulation-evoked dopamine
recordings, separate groups of mice received an infusion of either lidocaine or phosphatebuffered saline (PBS; vehicle control) into the ipsilateral DN. These present experiments
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help improve our understanding of dopamine lateralization and the relationship between
the cerebrocerebellar networks, both of which may provide targets for pharmacological
interventions in neuropathologies related to dopamine dysfunction.
Materials and Methods
Animals
Thirty-two male C57BL/6J mice (Jackson Laboratories, ME) were housed 3-5 per
cage in a temperature-controlled environment (21±1 °C) on a 12 hr light/dark cycle with
(lights on at 0600) and given food and water available ad libitum. All experiments were
approved by the Institutional Animal Care and Use Committee at the University of
Memphis and conducted in accordance with the National Institutes of Health Guidelines
for the Care and Use of Laboratory Animals. Efforts were made to reduce the number of
animals used and to minimize pain and discomfort.
Surgery
Mice were anesthetized with urethane (1.5 g/kg, i.p.) and placed in a stereotaxic
frame (David Kopf Instruments, Tujundga, CA) ensuring a flat skull. Body temperature
was maintained at 36±0.5 °C with a temperature-regulated heating pad (TC-1000; CWE,
NY). All stereotaxic coordinates are in mm from bregma, midline, and dura according to
the mouse atlas of Paxinos and Franklin (2001). In each mouse, a concentric bipolar
stimulating electrode (SNE-100, Rhodes Medical, CA) was implanted into either the left
cerebellar DN (AP +6.25, ML +2.0, and DV -2.0), or right DN (AP +6.25, ML -2.0, and
DV -2.0), or either the left MFB (AP +2.0, ML +1.1, DV -4.0) or right MFB (AP -2.0,
ML +1.1, DV -4.0). A stainless-steel auxiliary and Ag/AgCl reference electrode
combination was placed on the surface of cortical tissue contralateral to the stimulation
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electrode and -2.0 mm from bregma, and a carbon fiber recording electrode was
positioned in either the left NAc (AP +1.5, ML +1.0, and DV -4.0) or the right NAc (AP
+1.5, ML -1.0, and DV -3.8). For MFB stimulations, the recording electrode was placed
in the ipsilateral NAc; however, due to contralateral connections in cerebrocerebellar
circuity, the recording electrode was placed contralateral to cerebellar DN stimulation
(Bostan, Dunn, & Strick, 2010; Palesi et al., 2015).
Fixed-potential Amperometry
Fixed potential amperometry coupled with carbon fiber recording microelectrodes
has been confirmed as a valid technique for real-time monitoring of stimulation-evoked
dopamine release (Forster & Blaha, 2003; Lester, Rogers, & Blaha, 2010). All
amperometric recordings were made within a Faraday cage to increase signal to noise
ratio. A fixed potential (+0.8 V) was applied to the recording electrode, and oxidation
current was monitored continuously (10 K samples/sec) with an electrometer (ED401 ecorder 401 and EA162 Picostat, eDAQ Inc., Colorado Springs, CO) filtered at 50 Hz. A
series of cathodal current pulses was delivered to the stimulating electrode via an optical
isolator and programmable pulse generator (Iso-Flex/Master-8; AMPI, Jerusalem, Israel).
The stimulation protocol consisted of 20 monophasic 0.5 ms duration pulses (800
µAmps) at 50 Hz every 60 seconds to establish a baseline dopamine response. MFB and
DN stimulation-evoked dopamine was monitored for 30 minutes in each mouse.
Following these baseline recordings, a random subset of mice received a 1.0 µL infusion
(over 1.0 min) of either PBS (control) or the local anesthetic lidocaine (4%) into the DN
contralateral to the stimulation site, and dopamine recordings continued for 30 min.
Lidocaine blocks sodium channels and has been used during amperometric dopamine
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recordings to temporarily block functioning in a local brain site with peak lidocaine
responses occurring between 2-5 min post infusion (Lester et al., 2010). At the
conclusion of the amperometric recordings, recording electrodes were calibrated in vitro
with dopamine solutions (0.2-1.2 µM) administered by a flow injection system (Michael
& Wightman, 1999). Thus, change in dopamine oxidation current (nAmp) was converted
to dopamine concentration (µM).
Drugs
Urethane (U2500), lidocaine, (L7757), and dopamine (H8502) were obtained
from Sigma-Aldrich Chemical (St Louis, MO). Urethane was dissolved in distilled
water, and lidocaine and dopamine were dissolved in PBS (ph 7.4).
Histology
Upon the completion of each experimental session, an iron deposit was made in
the stimulation site by passing direct anodic current (100 μA and 1 mA, respectively) for
10 sec through the stimulating electrodes, and 1.0 μL cresyl violet stain was infused into
the cannula site. Mice were euthanized with a 0.25 ml intracardial injection of urethane
(0.345 g/ml). Brains were removed, immersed in 10% buffered formalin containing 0.1%
potassium ferricyanide (which causes a redox reaction at the stimulation site resulting in
a Prussian blue spot), and then stored in 30% sucrose/10% formalin solution for at least 1
week prior to sectioning. Using a cryostat at -20°C, 30 µm coronal sections were sliced,
and electrode placements were determined under a light microscope and recorded on
representative coronal diagrams confirming the intended sites were stimulated (Paxinos
& Franklin, 2001).

84

Data Analysis
To quantify MFB and DN stimulation-evoked dopamine efflux, pre-stimulation
current values were normalized to zero current values and data points occurring within a
range of 0.25 sec pre- and 50 sec post-onset of the stimulation were extracted from the
continuous record prior to and following drug infusion. An independent samples t-test
was used to assess hemispheric differences in baseline NAc dopamine release. A twoway mixed ANOVA was used to determine the effect of drug infusion (PBS or lidocaine)
and time (pre-infusion or 5 min post-infusion) on dopamine release. Dopamine release
post infusion was also converted to percent change (with the pre-infusion concentration
being 100%), and an independent samples t-test was used to determine if there was a
significant difference between PBS and lidocaine.
Results
NAc dopamine release following ipsilateral stimulation of the MFB
NAc dopamine release was quantified in each hemisphere as a function of peak
height following electrical stimulation of the ipsilateral MFB. No differences were
observed between the MFB stimulation-evoked dopamine release in the left NAc (M ±
SEM: 1.513 uM ± 0.357) compared to the right NAc (1.614 uM ± 0.466); t (8) = -0.172,
p = .867, d = 0.11 (Fig 1).
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Figure 1. Amperometric recordings of dopamine release in the left or right nucleus
accumbens (NAc) in response to electrical stimulation of the ipsilateral medial forebrain
bundle (MFB). (A) Profiles illustrate example responses from each recording site. Time
zero indicates the start of the train of 20 pulses at 50 Hz. (B) No mean (± SEM)
differences in dopamine release were observed between hemispheres.

NAc dopamine release following contralateral stimulation of the cerebellar DN
NAc dopamine release was quantified in each hemisphere as a function of peak
height following electrical stimulation of the contralateral DN. DN stimulation-evoked
dopamine release was significantly greater in the right NAc (M ± SEM: 0.018 uM ±
0.002) compared to the left NAc (0.011 uM ± 0.001); t (15) = -3.47, p = .003, d = 1.67
(Fig 2).
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Figure 2. Amperometric recordings of dopamine release in the left or right nucleus
accumbens (NAc) in response to electrical stimulation of the contralateral dentate nucleus
(DN) of the cerebellum. (A) Profiles illustrate example responses from each recording
site. Time zero indicates the start of the train of 20 pulses at 50 Hz. (B) Mean (± SEM)
differences in dopamine release were observed between hemispheres. * indicates p =
.003

NAc dopamine release following deactivation of the ipsilateral cerebellar DN
During contralateral DN stimulation-evoked dopamine recordings, separate mice
received an infusion of either lidocaine or PBS (control) into the ipsilateral DN to
determine the impact of hemispheric DN interactions on mesolimbic dopamine
transmission. In the left NAc (electrical stimulation in the right DN and infusion into the
left DN), a two-way mixed ANOVA revealed no significant interaction between the
infusion (PBS or lidocaine) and time (pre-infusion or 5 min post-infusion) on dopamine
release, F(1, 7) = 0.39, p = .55, ɳp2 = 0.05, and no main effect of infusion on dopamine
release, F(1, 7) = 0.36, p = .57, ɳp2 = 0.05. Similarly, in the right NAc (electrical
stimulation in the left DN and infusion into the right DN), a two-way mixed ANOVA
revealed no significant interaction between the drug infusion and time on dopamine
release, F(1, 6) = 0.13, p = .73, ɳp2 = 0.02, and no main effect of infusion on dopamine
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release, F(1, 6) = 0.01, p = .91, ɳp2 < 0.01. These results indicate that in both
hemispheric NAc recordings, dopamine release was not altered by either infusion (PBS
or lidocaine), suggesting DN cross-talk is not significantly influencing NAc dopamine
release. Figure 3 shows this data in terms of percent change with dopamine recordings
prior to infusion being 100%. Correspondingly, no differences in percent change in
dopamine release were observed between lidocaine and PBS infusions in either the left
NAc recordings [t (7) = 0.33, p = .76, d = 0.22, Fig 3A] or right NAc recordings [t (6) = 0.61, p = .57, d = 0.46, Fig 3B].

Figure 3. Mean (± SEM) nucleus accumbens (NAc) dopamine release in response to
electrical stimulation of the contralateral cerebellar dentate nucleus (DN) pre and post
infusion of PBS (control) or lidocaine (4%) in the ipsilateral DN. Neither PBS of
lidocaine infusion significantly altered dopamine release in the NAc (A: left, B: right).
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Discussion
The current study assessed the hemispheric lateralization of stimulation-evoked
dopamine in the NAc and the influence of the cerebellum in regulating this rewardassociated pathway. Results suggest that the mesolimbic pathway itself is not responsible
for asymmetrical lateralization of dopamine release given NAc dopamine release did not
differ between hemispheres when evoked by ipsilateral MFB stimulation. Instead,
dopaminergic asymmetry may originate from the cerebellar influence over these
pathways. Dopamine release was significantly greater in the right NAc relative to the left
when evoked downstream by the DN of the cerebellum. Furthermore, cross-hemispheric
talk between the left and right cerebellar DN does not seem to influence mesolimbic
dopamine release given that lidocaine infused into the DN opposite the electrically
stimulated DN did not alter dopamine release.
Cerebral and cerebellar hemispheres are known to be asymmetrical in structure
and function, and many researchers have shown this asymmetry extends to the
mesolimbic dopamine system (Hu, Shen, & Zhou, 2008; Hugdahl & Davidson, 2004).
Numerous studies using methods of protein analyses in rodents have found greater levels
of dopamine and its metabolites in the right NAc relative to the left (Andersen & Teicher,
1999; Budlin et al., 2008; Camp, Robinson, & Becker, 1984; Rosen et al., 1984). Protein
analyses such as the ones used in these previous studies are useful in determining
dopamine content levels but do not distinguish the neural pathways responsible for
modulating dopamine transmission. In vivo experiments have shown the cerebellum is
directly involved in regulating dopamine release in the mesocortical system (Mittleman et
al. 2008; Rogers et al., 2013). The present study extends these findings by showing
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cerebellar output also has the ability to modulate mesolimbic dopamine transmission,
with this modulation seemingly contributing to asymmetrically lateralized dopamine
release.
Dopamine release in the NAc is known to be associated with reward and
motivational processes (Cohen et al., 2012; Matsumoto & Hikosaka, 2009), and some
researchers submit that individual differences to natural rewards are a product of
asymmetry in the dopamine systems (Tomer et al., 2008). The present results support the
notion that reward processes in the brain may be lateralized between cerebrocerebellar
networks. This information may have considerable applications for many disorders
involving dysfunction of the mesolimbic dopamine system including schizophrenia,
Parkinson’s, ADHD, and addiction (Davis & Khan, 1991; Dougherty et al., 1999; Kish,
Shannak, & Hornykiewicz, 1988). For example, patients with unlilateral onset of
Parkinon’s disease often develop an asymmetry of dopamine deficiency (Djaldetti, Ziv,
& Melamed, 2006; Kempster, Gibb, Stern, & Lees, 1989). In one study, patients whose
motor symptoms began on the left side of the body performed more poorly on cognitive
tests than those with right-side onset (Tomer, Levin, & Weiner, 1993). These researchers
concluded that damage to right-hemisphere dopamine systems plays a greater role in
associated cognitive decline than left-hemisphere depletion. Optimal treatment for these
symptoms may involve administering different amounts of dopaminergic medication to
each hemisphere (Tomer, Aharon-Peretz, & Tsitrinbaum, 2007).
Although the present study is, to the best of our knowledge, the first to reveal
cerebellar influence on mesolimbic dopamine asymmetry, many studies support the
underlying theory that cerebellar asymmetry covaries with cerebral asymmetry,
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especially in abnormal pathology. For example, in stroke patients, cerebellar
lateralization switches in parallel with associated cerebral lateralization of language
functioning (Connor et al., 2006), and patients with left cerebral hemisphere congenital
focal lesions display a reorganized language network associated with the left cerebellum
(Lidzba et al., 2008). Furthermore, a positive correlation has been found between the
asymmetrical volume of cerebellum and the lateralized volume pattern in the cerebrum
(Snyder et al., 1995). These collective findings, along with our study, support the notion
that hemispheric lateralization tracks between the cerebellar and cerebral regions.
Conclusions
Previous animal studies have shown greater concentrations of dopamine in the
right NAc relative to the left. Although the present study did not find asymmetrical
release when directly stimulating the axons of the mesolimbic dopamine system, the
results do support lateralization of the mesolimbic dopamine system via modulation of
the cerebellar DN. Specifically, stimulation of the left DN leads to greater dopamine
release in the right NAc relative to right DN stimulation and left NAc dopamine release.
Cerebellar-mediated dopamine pathways have previously been shown to exhibit plasticity
and compensatory changes in the neural circuitry of rodent models of autism, providing a
potential foundation for the cerebellum to develop unique functional connections between
cerebral hemispheres (Rogers et al., 2013). Determining the functional relationship
between lateralized cerebrocerebellar networks may lead to novel targets for
pharmacological interventions.
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CHAPTER 5: SUMMARY AND CONCLUSIONS
Understanding normal neurochemical dopamine function is necessary not only to
identify potential pathology, but also to assess the effectiveness of drugs that might be
used for treatment. The nigrostriatal dopamine system consists of dopamine cell bodies in
the SNc that project to the dorsal striatum and play a role in the expression of motor
processes (Horvitz, 2000; Parent & Hazrati, 1995). The other major dopaminergic circuit,
the mesocorticolimbic dopamine system, consists of cell bodies in the VTA that project
to the amygdala, NAc, and mPFC (Fibiger & Phillips, 1988; Koob & Swerdlow, 1988).
The magnitude and timing of phasic dopamine release is critical for many diverse
functions in these output sites including reward, attention, anxiety, and decision-making
(Tsai et al., 2009). These differing behavioral processes emerge from variations in
dopamine autoreceptor, uptake, and release sites, which lead to site-specific differences
in dopamine concentrations during synchronous phasic firing (Venton et al., 2003).
In Chapter 2 we observed and quantified differences in the neurochemical profile
of phasic dopamine release in major dopaminergic sites including the striatum, NAc,
amygdala, and prefrontal cortex after stimulation of the MFB. We also provided evidence
that supported differing behavioral processes in the brain may emerge as a result of
spatial and temporal variations in the phasic response. Specifically, these findings
indicate that phasic dopamine may have different modes of communication between
striatal and corticolimbic regions, with the first being profuse in concentration, rapid, and
synaptically confined, and the second being more restricted in concentration but longerlasting and spatially dispersed. Understanding the various aspects of regional differences
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in phasic dopamine transmission may be useful for predicting and manipulating the
effects of drugs on dopamine-dependent behaviors.
In Chapter 3 we introduced the notion of a cerebellar influence on the nigrostriatal
dopamine system by identifying a pathway originating in the cerebellar dentate that
projects to the dorsomedial striatum and examining potential pathology of this pathway in
a rodent model of Fragile-X syndrome. Structural abnormalities within the DN of the
cerebellum is one of the most common neuronal abnormalities in individuals with ASDs,
specifically reduction in Purkinje cells (Hallahan et al., 2009; McKelvey, Lambert,
Mottron, & Shevell, 1995; Murakami, Courchesne Haas, Press, & Yueng-Courchesne,
1992). Input from the cerebral cortex to the cerebellum originates from various types of
nuclei (e.g., visual, spatial, premotor, motor), but complex synchronization and funneling
of information allows Purkinje cells to provide the sole source of output from the
cerebellar cortex, via activity on the DN (Voogd & Glickstein, 1998). In this study, we
used amperometry to determine if DN-stimulation evoked dopamine response within the
dorsomedial striatum is attenuated in mutant Fragile-X mice in comparison to their
wildtype controls. Although we found no significant difference of DA release in this area,
examination of other basal ganglia circuitry (e.g., nucleus accumbens, substantia nigra,
dorsolateral striatum) may reveal neural abnormalities significant to resolving
degenerative symptoms seen in ASD.
The findings reported in Chapter 4 further are intended to aid in investigation of
cerebrocerebellar networks and examine the possibility of functional asymmetry in the
dopaminergic system. In vivo experiments have shown that the cerebellum is directly
involved in regulation of the mesolimbic dopamine system by way of connections from

103

the DN to the VTA (Mittleman et al., 2008; Rogers et al., 2013). Additionally, cerebral
and cerebellar hemispheres are known to be asymmetrical in structure and function, and
this asymmetry extends to the mesolimbic dopamine system (Hu, Shen, & Zhou, 2008;
Hugdahl & Davidson, 2004). We sought to determine if cerebral or cerebellar networks
underlie this laterality by measuring stimulation-evoked dopamine release in the NAC
through pathways originating in either the cerebellar DN or the cerebral MFB.
We found significant differences in the amplitude of phasic dopamine release in
the DN-NAc systems, but not the MFB-NAc pathways. Thus, the results in Chapter 4
support the notion that reward processes in the brain may be lateralized between
cerebrocerebellar networks. These results provide insight about the relationship between
the cerebrocerebellar networks and lateralization of the dopaminergic system, as well as
reveal potentially novel targets for pharmacological interventions in neuropathology of
the cerebellum. For example, these results may provide important information relevant to
many disorders involving dysfunction of the dopamine system including schizophrenia,
Parkinson’s, ADHD, and addiction (Davis & Khan, 1991; Dougherty et al., 1999; Kish,
Shannak, & Hornykiewicz, 1988). Future studies should target other neural outputs of the
dopaminergic system and determine if cerebellar-mediated asymmetry is a prominent
feature of these nuclei as well.
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